{"content":"<li class=\"n-box-item date-title\" data-end=\"1372737599\" data-start=\"1372651200\" data-txt=\"Friday, December 20, 2019\">Monday, July  1, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1116182\" data-ts=\"1372723199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACUR\" target=\"_blank\">ACUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116182\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Acura Pharmaceuticals (OTC:ACUR) had a solid day today, finishing up over 18% after...</a></h4><p>Shares of Acura Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a>) had a solid day today, finishing up over <font color=\"green\">18%</font> after the company said Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) will expand commercialization of Oxecta Tablets to health care providers in Q4. These campaign will be directed towards a national cross section of healthcare professionals who treat pain, but will not include the use of field representatives. <a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a> receives tiered royalties ranging from 5% to 25% on net sales the pain killer.</p><div class=\"tiny-share-widget\" data-id=\"1116182\" data-linked=\"Shares of Acura Pharmaceuticals (OTC:ACUR) had a solid day today, finishing up over 18% after...\" data-tweet=\"$ACUR $ACUR $PFE - Shares of Acura Pharmaceuticals (OTC:ACUR) had a solid day today, finishing up over 18% after the company said Pfizer (NYSE:PFE) will expand commercialization of Oxecta Tablets to health care providers in Q4. These campaign will be di... https://seekingalpha.com/news/1116182?source=tweet\" data-url=\"https://seekingalpha.com/news/1116182\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1116162\" data-ts=\"1372719421\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLAB\" target=\"_blank\">SLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116162\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Labs (NASDAQ:SLAB) says it&#39;s completed its acquisition of Energy Micro AS, giving it...</a></h4><p>Silicon Labs (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SLAB\" title=\"Silicon Laboratories, Inc.\">SLAB</a>) says it's completed its acquisition of Energy Micro AS, giving it entrance into the smart energy, home automation, security and portable electronics markets. The deal's closing means Energy Micro will receive an up-front payment of $115M in cash, plus approximately $55M in deferred and earn-out consideration. Shares <font color=\"red\">-3.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1116162\" data-linked=\"Silicon Labs (NASDAQ:SLAB) says it&#39;s completed its acquisition of Energy Micro AS, giving it...\" data-tweet=\"$SLAB - Silicon Labs (NASDAQ:SLAB) says it&#39;s completed its acquisition of Energy Micro AS, giving it entrance into the smart energy, home automation, security and portable electronics markets. The deal&#39;s closing means Energy Micro will receive an up-fro... https://seekingalpha.com/news/1116162?source=tweet\" data-url=\"https://seekingalpha.com/news/1116162\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1116142\" data-ts=\"1372717777\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDSN\" target=\"_blank\">HDSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116142\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hudson Technologies (NASDAQ:HDSN) gets hammered in the post-session after the industrial...</a></h4><p>Hudson Technologies (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HDSN\" title=\"Hudson Technologies, Inc.\">HDSN</a>) gets hammered in the post-session after the industrial equipment wholesaler says it expects to report Q2 earnings in a range from $0.00 to $0.01 per share, trailing Street estimates by at least $0.14 per share. Revenue declined 29.5% Y/Y to $15.5M, also lagging analyst expectations of $24.67M. The company cites unusually cool spring weather for lower sales of air conditioning equipment for the miss. Shares <font color=\"red\">-24.4%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1116142\" data-linked=\"Hudson Technologies (NASDAQ:HDSN) gets hammered in the post-session after the industrial...\" data-tweet=\"$HDSN - Hudson Technologies (NASDAQ:HDSN) gets hammered in the post-session after the industrial equipment wholesaler says it expects to report Q2 earnings in a range from $0.00 to $0.01 per share, trailing Street estimates by at least $0.14 per share. ... https://seekingalpha.com/news/1116142?source=tweet\" data-url=\"https://seekingalpha.com/news/1116142\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1116062\" data-ts=\"1372714643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVA\" target=\"_blank\">DVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116062\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DaVita HealthCare (NYSE:DVA) slips in the post-session on reports the U.S. Medicare program...</a></h4><p>DaVita HealthCare (NYSE:<a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a>) slips in the post-session on reports the U.S. Medicare program <a target=\"_blank\" href=\"http://www.streetinsider.com/Trader+Talk/DaVita+%28DVA%29+Stock+Hit%3B+Medicare+Plan+Seeks+to+Cut+Payments+to+Dialysis+Centers/8466132.html\">plans to cut payments</a> to dialysis centers by 9.4% next year, according to a proposal posted online Monday afternoon. Cuts are part of a budget balancing law passed last year. Fresenius Medical Care (NYSE:<a href=\"https://seekingalpha.com/symbol/FMS\" title=\"Fresenius Medical Care AG &amp; Co. KGAA\">FMS</a>) also trades lower on the news. <a href=\"https://seekingalpha.com/symbol/DVA\" title=\"DaVita HealthCare Partners Inc.\">DVA</a> <font color=\"red\">-5.5%</font>, <a href=\"https://seekingalpha.com/symbol/FMS\" title=\"Fresenius Medical Care AG &amp; Co. KGAA\">FMS</a> <font color=\"red\">-1.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1116062\" data-linked=\"DaVita HealthCare (NYSE:DVA) slips in the post-session on reports the U.S. Medicare program...\" data-tweet=\"$DVA $DVA $FMS - DaVita HealthCare (NYSE:DVA) slips in the post-session on reports the U.S. Medicare program plans to cut payments to dialysis centers by 9.4% next year, according to a proposal posted online Monday afternoon. Cuts are part of a budget b... https://seekingalpha.com/news/1116062?source=tweet\" data-url=\"https://seekingalpha.com/news/1116062\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1116052\" data-ts=\"1372714202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRP\" target=\"_blank\">TRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: TRP +8%. XRTX +6%. ZNGA +6%. TSPT +4%. NWS +3%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/TRP' title='TransCanada Corporation'>TRP</a> <font color=\"green\">+8%</font>. <a href='https://seekingalpha.com/symbol/XRTX' title='Xyratex Ltd.'>XRTX</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a> <font color=\"green\">+6%</font>. TSPT <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/NWS' title='News Corporation'>NWS</a> <font color=\"green\">+3%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a> <font color=\"red\">-22%</font>. <a href='https://seekingalpha.com/symbol/FMS' title='Fresenius Medical Care AG & Co. KGAA'>FMS</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/GSE' title='GSE Holding'>GSE</a> <font color=\"red\">-2%</font>. <a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a> <font color=\"red\">-2%</font>. <a href='https://seekingalpha.com/symbol/TEO' title='Telecom Argentina S.A.'>TEO</a> <font color=\"red\">-1%</font>.<div class=\"tiny-share-widget\" data-id=\"1116052\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: TRP +8%. XRTX +6%. ZNGA +6%. TSPT +4%. NWS +3%....\" data-tweet=\"$TRP $TRP $XRTX - After-hours top gainers, as of 5:15 p.m.: TRP +8%. XRTX +6%. ZNGA +6%. TSPT +4%. NWS +3%. After-hours top losers: ACHN -22%. FMS -7%. GSE -2%. THO -2%. TEO -1%. https://seekingalpha.com/news/1116052?source=tweet\" data-url=\"https://seekingalpha.com/news/1116052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1116012\" data-ts=\"1372713435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1116012\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Lazard&#39;s downgrade of Broadcom (BRCM -1.8%) and upgrade of Marvell (MRVL +0.4%): analyst...</a></h4><a href=\"http://blogs.barrons.com/techtraderdaily/2013/07/01/brcm-lazard-says-hold-on-lack-of-catalysts-ups-mrvl-to-buy-on-baseband/?mod=BOLBlog&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+barrons%2Ftechtraderdaily%2Ffeed+%28BARRONS.com+Blog%3A+Tech+Trader+Daily%29\" target=\"_blank\">More</a> on Lazard's <a href=\"https://seekingalpha.com/currents/post/1114492\" target=\"_blank\">downgrade</a> of Broadcom (BRCM <font color='red'>-1.8%</font>) and upgrade of Marvell (<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color='green'>+0.4%</font>): analyst Daniel Amir argues Broadcom's (dominant) combo chip share has nowhere to go but down, that <a href=\"https://seekingalpha.com/currents/post/822921\" target=\"_blank\">4G LTE baseband chip</a> sales will take time, and that heavy investments/opex spell a lack of operating leverage. Meanwhile, he thinks rival Marvell's 3G baseband business could be a positive catalyst: the company has <a href=\"http://www.pcmag.com/article2/0,2817,2415524,00.asp\" target=\"_blank\">launched quad-core chips</a>, is expanding beyond China, and has scored design wins with Samsung, Huawei, ZTE, and HTC.&nbsp; Moreover, the baseband wins could lead to combo chip wins. <a href=\"https://seekingalpha.com/currents/post/1104932\" target=\"_blank\">Brean</a> upgraded Marvell last week. (<a href=\"https://seekingalpha.com/currents/post/1084152\" target=\"_blank\">Broadcom 3G basebands</a>)<div class=\"tiny-share-widget\" data-id=\"1116012\" data-linked=\"More on Lazard&#39;s downgrade of Broadcom (BRCM -1.8%) and upgrade of Marvell (MRVL +0.4%): analyst...\" data-tweet=\"$AVGO $AVGO $MRVL - More on Lazard&#39;s downgrade of Broadcom (BRCM -1.8%) and upgrade of Marvell (MRVL +0.4%): analyst Daniel Amir argues Broadcom&#39;s (dominant) combo chip share has nowhere to go but down, that 4G LTE baseband chip sales will take time, an... https://seekingalpha.com/news/1116012?source=tweet\" data-url=\"https://seekingalpha.com/news/1116012\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115972\" data-ts=\"1372711931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115972\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achillion Pharmaceuticals (NASDAQ:ACHN) resumes trading, now -20% AH.</a></h4>Achillion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a>) <a href=\"https://seekingalpha.com/market_currents/post/1115832\" target=\"_blank\">resumes</a> trading, now <font color=\"red\">-20%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1115972\" data-linked=\"Achillion Pharmaceuticals (NASDAQ:ACHN) resumes trading, now -20% AH.\" data-tweet=\"$ACHN - Achillion Pharmaceuticals (NASDAQ:ACHN) resumes trading, now -20% AH. https://seekingalpha.com/news/1115972?source=tweet\" data-url=\"https://seekingalpha.com/news/1115972\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115962\" data-ts=\"1372711622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLM\" target=\"_blank\">SHLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115962\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of A. Schulman (NASDAQ:SHLM) resume trading, currently -14% AH.</a></h4>Shares of A. Schulman (NASDAQ:<a href='https://seekingalpha.com/symbol/SHLM' title='A. Schulman, Inc.'>SHLM</a>) <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1115892\">resume</a> trading, currently <font color=\"red\">-14%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1115962\" data-linked=\"Shares of A. Schulman (NASDAQ:SHLM) resume trading, currently -14% AH.\" data-tweet=\"$SHLM - Shares of A. Schulman (NASDAQ:SHLM) resume trading, currently -14% AH. https://seekingalpha.com/news/1115962?source=tweet\" data-url=\"https://seekingalpha.com/news/1115962\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115952\" data-ts=\"1372711236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBT\" target=\"_blank\">AMBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115952\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Annual reconstitution of Russell&amp;rsquo;s U.S. indexes may help explain some of today&#39;s big...</a></h4>Annual reconstitution of Russell&rsquo;s U.S. indexes may help explain some of today's big movers among smallcaps; the event typically is viewed as a trading opportunity. Among Russell deletions: <a href='https://seekingalpha.com/symbol/AMBT' title='Ambient Corp'>AMBT</a> <font color=\"green\">+22.4%</font>, <a href='https://seekingalpha.com/symbol/ACUR' title='Acura Pharmaceuticals, Inc.'>OTC:ACUR</a> <font color=\"green\">+18%</font>, <a href='https://seekingalpha.com/symbol/DM' title='Dominion Midstream Partners LP'>DM</a> <font color=\"green\">+14.7%</font>, <a href='https://seekingalpha.com/symbol/FALC' title='FalconStor Software, Inc.'>OTC:FALC</a> <font color=\"red\">-12.4%</font>, <a href='https://seekingalpha.com/symbol/CDZI' title='Cadiz, Inc.'>CDZI</a> <font color=\"green\">+12.4%</font>, <a href='https://seekingalpha.com/symbol/HNR' title='Harvest Natural Resources, Inc.'>HNR</a> <font color=\"green\">+10.9%</font>, Among additions: <a href='https://seekingalpha.com/symbol/INSM' title='Insmed, Inc.'>INSM</a> <font color=\"red\">-18.7%</font>, <a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color=\"red\">-13.5%</font>, <a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color=\"green\">+10%</font>. (<a target=\"_blank\" href=\"http://www.briefing.com/common/images/content/pagecontent/InPlayEQ/20130701104218Russell2013.JPG\">full list</a>)<div class=\"tiny-share-widget\" data-id=\"1115952\" data-linked=\"Annual reconstitution of Russell&amp;rsquo;s U.S. indexes may help explain some of today&#39;s big...\" data-tweet=\"$AMBT $AMBT $ACUR - Annual reconstitution of Russell&amp;rsquo;s U.S. indexes may help explain some of today&#39;s big movers among smallcaps; the event typically is viewed as a trading opportunity. Among Russell deletions: AMBT +22.4%, OTC:ACUR +18%, DM +14.7%... https://seekingalpha.com/news/1115952?source=tweet\" data-url=\"https://seekingalpha.com/news/1115952\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115932\" data-ts=\"1372711129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFOP\" target=\"_blank\">AFOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115932\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance Fiber (NASDAQ:AFOP) +4.4% AH after announcing it expects to post Q2 revenue of $19M+,...</a></h4><p>Alliance Fiber (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AFOP\" title=\"Alliance Fiber Optic Products, Inc.\">AFOP</a>) <font color=\"green\">+4.4%</font> AH after announcing it expects to post Q2 revenue of $19M+, above prior guidance of $16M and a $16.2M consensus. The company adds customer demand \"remained strong till the end of quarter.\" SA contributor Inflection Point Investing <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1075352\">recently declared</a> the passive optical component vendor, along with peer NeoPhotonics and system vendor Infinera, to be play on soaring 100G optical networking hardware demand. Shares <font color=\"green\">rose 9.4%</font> in regular trading. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1115932\" data-linked=\"Alliance Fiber (NASDAQ:AFOP) +4.4% AH after announcing it expects to post Q2 revenue of $19M+,...\" data-tweet=\"$AFOP - Alliance Fiber (NASDAQ:AFOP) +4.4% AH after announcing it expects to post Q2 revenue of $19M+, above prior guidance of $16M and a $16.2M consensus. The company adds customer demand &quot;remained strong till the end of quarter.&quot; SA contributor Inflec... https://seekingalpha.com/news/1115932?source=tweet\" data-url=\"https://seekingalpha.com/news/1115932\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115892\" data-ts=\"1372710206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLM\" target=\"_blank\">SHLM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115892\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A. Schulman (NASDAQ:SHLM): Q3 misses hard across the board as net sales declined by 3% year over...</a></h4>A. Schulman (NASDAQ:<a href='https://seekingalpha.com/symbol/SHLM' title='A. Schulman, Inc.'>SHLM</a>): <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1115872\">Q3 misses hard</a> across the board as net sales declined by 3% year over year. Additionally, the company lowers FY13 EPS guidance to $1.70 - $1.80&nbsp; from $2.08 - $2.13, missing the Street's per-share expectation of $2.01. It cites continued inconsistency in European markets and additional costs in Latin America for the downward revision. Shares currently halted AH.<div class=\"tiny-share-widget\" data-id=\"1115892\" data-linked=\"A. Schulman (NASDAQ:SHLM): Q3 misses hard across the board as net sales declined by 3% year over...\" data-tweet=\"$SHLM - A. Schulman (NASDAQ:SHLM): Q3 misses hard across the board as net sales declined by 3% year over year. Additionally, the company lowers FY13 EPS guidance to $1.70 - $1.80&amp;nbsp; from $2.08 - $2.13, missing the Street&#39;s per-share expectation of $2... https://seekingalpha.com/news/1115892?source=tweet\" data-url=\"https://seekingalpha.com/news/1115892\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115822\" data-ts=\"1372709619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRTX\" target=\"_blank\">XRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115822\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xyratex (NASDAQ:XRTX): FQ2 EPS of $0.10 beats by $0.15. Revenue of $216.2M beats by $13.04M....</a></h4><b>Xyratex (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XRTX\" title=\"Xyratex Ltd.\">XRTX</a>):</b> FQ2 EPS of $0.10 <font color=\"green\">beats by $0.15</font>. Revenue of $216.2M <font color=\"green\">beats by $13.04M</font>. Shares  <font color=\"green\">+1.23%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1115822\" data-linked=\"Xyratex (NASDAQ:XRTX): FQ2 EPS of $0.10 beats by $0.15. Revenue of $216.2M beats by $13.04M....\" data-tweet=\"$XRTX - Xyratex (NASDAQ:XRTX): FQ2 EPS of $0.10 beats by $0.15. Revenue of $216.2M beats by $13.04M. Shares +1.23% AH. (PR) https://seekingalpha.com/news/1115822?source=tweet\" data-url=\"https://seekingalpha.com/news/1115822\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115772\" data-ts=\"1372708679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115772\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">$160/share is apparently the Street high takeout target for Onyx Pharmaceuticals (ONXX +50.9%)...</a></h4><p>$160/share is apparently the <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3721829/update-brean-capital-sees-onyx-buyout-price-at-160\">Street high takeout target</a> for Onyx Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a> <font color=\"green\">+50.9%</font>) and it comes from Brean Capital's Gene Mack who says it \"reflects a multiple of peak sales of three times the estimate of the company's key drug of $4B in sales [which is] rather conservative and well-within the range of other biotech deals.\" Other numbers being thrown about are $130-140/share from Maxim Group and $140-150 from Bernstein and Deutsche.</p><div class=\"tiny-share-widget\" data-id=\"1115772\" data-linked=\"$160/share is apparently the Street high takeout target for Onyx Pharmaceuticals (ONXX +50.9%)...\" data-tweet=\"$ONXX - $160/share is apparently the Street high takeout target for Onyx Pharmaceuticals (ONXX +50.9%) and it comes from Brean Capital&#39;s Gene Mack who says it &quot;reflects a multiple of peak sales of three times the estimate of the company&#39;s key drug of $4... https://seekingalpha.com/news/1115772?source=tweet\" data-url=\"https://seekingalpha.com/news/1115772\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115762\" data-ts=\"1372708535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNVC\" target=\"_blank\">GNVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115762\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GenVec (GNVC +2.8%) says it&#39;s terminating the employment of 30 of its remaining 41 employees....</a></h4><p>GenVec (<a href=\"https://seekingalpha.com/symbol/GNVC\" title=\"GenVec, Inc.\">GNVC</a> <font color=\"green\">+2.8%</font>) says it's <a href=\"http://www.sec.gov/Archives/edgar/data/934473/000114420413037255/v348931_8k.htm\" target=\"_blank\">terminating the employment</a> of 30 of its remaining 41 employees. The termination is expected to be completed effective June 30, 2013. It estimates that about $311,785 of expenses will be incurred in Q2 due to the position eliminations. The move comes as no surprise, considering that its board announced late last month that it had <a href=\"https://seekingalpha.com/market_currents/post/1049091\" target=\"_blank\">approved the liquidation</a> and dissolution of the company.</p><div class=\"tiny-share-widget\" data-id=\"1115762\" data-linked=\"GenVec (GNVC +2.8%) says it&#39;s terminating the employment of 30 of its remaining 41 employees....\" data-tweet=\"$GNVC - GenVec (GNVC +2.8%) says it&#39;s terminating the employment of 30 of its remaining 41 employees. The termination is expected to be completed effective June 30, 2013. It estimates that about $311,785 of expenses will be incurred in Q2 due to the pos... https://seekingalpha.com/news/1115762?source=tweet\" data-url=\"https://seekingalpha.com/news/1115762\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115742\" data-ts=\"1372707554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HFC\" target=\"_blank\">HFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115742\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Refiners HollyFrontier (HFC -5.2%), Marathon Petroleum (MPC -0.7%) and Valero (VLO -1.4%) are...</a></h4><p>Refiners HollyFrontier (<a href=\"https://seekingalpha.com/symbol/HFC\" title=\"HollyFrontier Corp.\">HFC</a> <font color=\"red\">-5.2%</font>), Marathon Petroleum (<a href=\"https://seekingalpha.com/symbol/MPC\" title=\"Marathon Petroleum Corp.\">MPC</a> <font color=\"red\">-0.7%</font>) and Valero (<a href=\"https://seekingalpha.com/symbol/VLO\" title=\"Valero Energy Corporation\">VLO</a> <font color=\"red\">-1.4%</font>) are <a href=\"http://finance.yahoo.com/news/sector-snap-oil-refiners-184059862.html\" target=\"_blank\">downgraded</a> to Underweight from Neutral at J.P. Morgan, which says traditionally weaker H2 results and narrowing differentials between Brent prices and WTI will keep shares range-bound even as the companies' long-term finances still look good. The firm prefers Phillips 66 (<a href=\"https://seekingalpha.com/symbol/PSX\" title=\"Phillips 66\">PSX</a> <font color=\"green\">+0.1%</font>) and Tesoro (TSO <font color=\"red\">-0.6%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1115742\" data-linked=\"Refiners HollyFrontier (HFC -5.2%), Marathon Petroleum (MPC -0.7%) and Valero (VLO -1.4%) are...\" data-tweet=\"$HFC $HFC $MPC - Refiners HollyFrontier (HFC -5.2%), Marathon Petroleum (MPC -0.7%) and Valero (VLO -1.4%) are downgraded to Underweight from Neutral at J.P. Morgan, which says traditionally weaker H2 results and narrowing differentials between Brent pr... https://seekingalpha.com/news/1115742?source=tweet\" data-url=\"https://seekingalpha.com/news/1115742\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115722\" data-ts=\"1372707076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115722\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array Biopharma&#39;s (ARRY +4%) ARRY-520 is an underappreciated play on multiple myeloma, Wells...</a></h4><p>Array Biopharma's (<a href=\"https://seekingalpha.com/symbol/ARRY\" title=\"Array BioPharma Inc.\">ARRY</a> <font color=\"green\">+4%</font>) <a href=\"http://www.arraybiopharma.com/ProductPipeline/Cancer/KSP.asp\" target=\"_blank\">ARRY-520</a> is an <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3721752/wells-fargo-says-outside-interest-in-multiple-myeloma-sp\" target=\"_blank\">underappreciated</a> play on multiple myeloma, Wells Fargo's Matthew Adams says, and recent action (<a href=\"https://seekingalpha.com/currents/post/1114162\" target=\"_blank\">Onyx/Amgen</a> and <a href=\"https://seekingalpha.com/currents/post/1109142\" target=\"_blank\">Celgene/ MorphoSys</a>) indicates \"significant interest\" in the space.</p><div class=\"tiny-share-widget\" data-id=\"1115722\" data-linked=\"Array Biopharma&#39;s (ARRY +4%) ARRY-520 is an underappreciated play on multiple myeloma, Wells...\" data-tweet=\"$ARRY - Array Biopharma&#39;s (ARRY +4%) ARRY-520 is an underappreciated play on multiple myeloma, Wells Fargo&#39;s Matthew Adams says, and recent action (Onyx/Amgen and Celgene/ MorphoSys) indicates &quot;significant interest&quot; in the space. https://seekingalpha.com/news/1115722?source=tweet\" data-url=\"https://seekingalpha.com/news/1115722\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115712\" data-ts=\"1372706911\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLS\" target=\"_blank\">XLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115712\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ITT Exelis (XLS +2.5%) trades up today after saying it&#39;s been selected by Raytheon Company...</a></h4><p>ITT Exelis (<a href=\"https://seekingalpha.com/symbol/XLS\" title=\"Exelis Inc.\">XLS</a> <font color=\"green\">+2.5%</font>) trades up today after saying it's been selected by Raytheon Company (NYSE:<a href=\"https://seekingalpha.com/symbol/RTN\" title=\"Raytheon Company\">RTN</a>) to supply antenna subsystems for the DoD's international ballistic defense system. The antennas will be fielded as part of the Standard Missile-3 program, a cooperative development program between the U.S. Department of Defense and the Ministry of Defense of Japan, scheduled to be deployed in 2018.</p><div class=\"tiny-share-widget\" data-id=\"1115712\" data-linked=\"ITT Exelis (XLS +2.5%) trades up today after saying it&#39;s been selected by Raytheon Company...\" data-tweet=\"$XLS $XLS $RTN - ITT Exelis (XLS +2.5%) trades up today after saying it&#39;s been selected by Raytheon Company (NYSE:RTN) to supply antenna subsystems for the DoD&#39;s international ballistic defense system. The antennas will be fielded as part of the Standar... https://seekingalpha.com/news/1115712?source=tweet\" data-url=\"https://seekingalpha.com/news/1115712\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115692\" data-ts=\"1372706557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMSI\" target=\"_blank\">MMSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115692\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merit Medical Systems (MMSI +2%) says it&#39;s received 510(k) clearance from the FDA for its...</a></h4><p>Merit Medical Systems (<a href=\"https://seekingalpha.com/symbol/MMSI\" title=\"Merit Medical Systems, Inc.\">MMSI</a> <font color=\"green\">+2%</font>) says it's received 510(k) clearance from the FDA for its basixTOUCH, a high-pressure inflation device. The company also announced that it has been notified by its embolic business partner in Japan, Nippon Kayaku, that it has received approval from Japan's Pharmaceuticals and Medical Devices Agency for Embosphere and HepaSphere Microspheres as medical devices for arterial embolization in patients with hypervascular tumors and arteriovenous malformations.</p><div class=\"tiny-share-widget\" data-id=\"1115692\" data-linked=\"Merit Medical Systems (MMSI +2%) says it&#39;s received 510(k) clearance from the FDA for its...\" data-tweet=\"$MMSI - Merit Medical Systems (MMSI +2%) says it&#39;s received 510(k) clearance from the FDA for its basixTOUCH, a high-pressure inflation device. The company also announced that it has been notified by its embolic business partner in Japan, Nippon Kayaku,... https://seekingalpha.com/news/1115692?source=tweet\" data-url=\"https://seekingalpha.com/news/1115692\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115682\" data-ts=\"1372706187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EOG\" target=\"_blank\">EOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115682\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EOG Resources (EOG +3%) is on the move as Jefferies raises its target price for the Buy-rated...</a></h4><p>EOG Resources (<a href=\"https://seekingalpha.com/symbol/EOG\" title=\"EOG Resources, Inc.\">EOG</a> <font color=\"green\">+3%</font>) is on the move as Jefferies <a href=\"http://finance.yahoo.com/news/shares-eog-resources-rise-analyst-173736467.html\" target=\"_blank\">raises its target price</a> for the Buy-rated shares to $174 from $160, predicting new techniques could soon boost production at its Eagle Ford wells. The firm says EOG is drilling some of the best shale wells on the eastern part of its acreage; its western wells aren't as  strong but are improving, helped by the use of more advanced  technology.</p><div class=\"tiny-share-widget\" data-id=\"1115682\" data-linked=\"EOG Resources (EOG +3%) is on the move as Jefferies raises its target price for the Buy-rated...\" data-tweet=\"$EOG - EOG Resources (EOG +3%) is on the move as Jefferies raises its target price for the Buy-rated shares to $174 from $160, predicting new techniques could soon boost production at its Eagle Ford wells. The firm says EOG is drilling some of the best ... https://seekingalpha.com/news/1115682?source=tweet\" data-url=\"https://seekingalpha.com/news/1115682\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115672\" data-ts=\"1372706063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASRV\" target=\"_blank\">ASRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115672\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmeriServ Financial (ASRV +9.1%) bounces back from a big Friday loss with SA Pro author...</a></h4><p>AmeriServ Financial (<a href=\"https://seekingalpha.com/symbol/ASRV\" title=\"AmeriServ Financial Inc.\">ASRV</a> <font color=\"green\">+9.1%</font>) bounces back from a big Friday loss with SA Pro author Intangible Valuation <a href=\"https://seekingalpha.com/article/1529372-ameriserv-financial-20-discount-to-tangible-book-bright-long-term-prospects\" target=\"_blank\">pointing out</a> this morning (embargoed until Tuesday) not to expect the Pennsylvania community bank to continue trading at a 20% discount to tangible book value for long.</p><div class=\"tiny-share-widget\" data-id=\"1115672\" data-linked=\"AmeriServ Financial (ASRV +9.1%) bounces back from a big Friday loss with SA Pro author...\" data-tweet=\"$ASRV - AmeriServ Financial (ASRV +9.1%) bounces back from a big Friday loss with SA Pro author Intangible Valuation pointing out this morning (embargoed until Tuesday) not to expect the Pennsylvania community bank to continue trading at a 20% discount ... https://seekingalpha.com/news/1115672?source=tweet\" data-url=\"https://seekingalpha.com/news/1115672\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115662\" data-ts=\"1372705608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDE\" target=\"_blank\">CDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115662\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coeur d&#39;Alene (CDE -3.4%) shares have been slashed by BMO&#39;s downgrade, but the firm also cut...</a></h4><p>Coeur d'Alene (<a href=\"https://seekingalpha.com/symbol/CDE\" title=\"Coeur Mining, Inc.\">CDE</a> <font color=\"red\">-3.4%</font>) shares have been slashed by BMO's <a href=\"https://seekingalpha.com/currents/post/1115192\" target=\"_blank\">downgrade</a>, but the firm also cut four other miners to Underperform, including Barrick Gold (ABX <font color=\"red\">-2.3%</font>), whose deferral of the Pascua-Lama project is \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3720925/update-bmo-capital-markets-downgrades-barrick-gold-to-un\" target=\"_blank\">a step in the right direction</a>\" toward reducing company-wide costs. Also lowered are three silver producers (<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3721025/update-bmo-capital-downgrades-pan-american-silver-to-und\" target=\"_blank\">I</a>, <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3720925/update-bmo-capital-markets-downgrades-barrick-gold-to-un\" target=\"_blank\">II</a>, <a href=\"http://www.streetinsider.com/Downgrades/BMO+Capital+Downgrades+Fortuna+Silver+Mines+%28FSM%29+to+Underperform/8463130.html\" target=\"_blank\">III</a>): Pan American (<a href=\"https://seekingalpha.com/symbol/PAAS\" title=\"Pan American Silver Corp.\">PAAS</a> <font color=\"green\">+2.1%</font>), Endeavour (<a href=\"https://seekingalpha.com/symbol/EXK\" title=\"Endeavour Silver Corp.\">EXK</a> <font color=\"red\">-1.1%</font>) and Fortuna (<a href=\"https://seekingalpha.com/symbol/FSM\" title=\"Fortuna Silver Mines\">FSM</a> <font color=\"red\">-3%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1115662\" data-linked=\"Coeur d&#39;Alene (CDE -3.4%) shares have been slashed by BMO&#39;s downgrade, but the firm also cut...\" data-tweet=\"$CDE $CDE $GOLD - Coeur d&#39;Alene (CDE -3.4%) shares have been slashed by BMO&#39;s downgrade, but the firm also cut four other miners to Underperform, including Barrick Gold (ABX -2.3%), whose deferral of the Pascua-Lama project is &quot;a step in the right direc... https://seekingalpha.com/news/1115662?source=tweet\" data-url=\"https://seekingalpha.com/news/1115662\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115602\" data-ts=\"1372704623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACTG\" target=\"_blank\">ACTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115602\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acacia (ACTG +5.2%) outperforms after acquiring 4 fresh sets of patent portfolios (I, II, III,...</a></h4><p>Acacia (<a href=\"https://seekingalpha.com/symbol/ACTG\" title=\"Acacia Research Corporation\">ACTG</a> <font color=\"green\">+5.2%</font>) outperforms after acquiring 4 fresh sets of patent portfolios (I, II, III, IV), and announcing licensing deals (I, II, III) with VMware (NYSE:<a href=\"https://seekingalpha.com/symbol/VMW\" title=\"VMware, Inc.\">VMW</a>) and 2 other companies. The patent purchases are related to consumer electronics content security, printing tech, and high-speed circuit interconnect and display control. The non-printing patents were acquired from an unnamed \"major semiconductor technology company.\" The VMware deal resolves an existing infringement suit.</p><div class=\"tiny-share-widget\" data-id=\"1115602\" data-linked=\"Acacia (ACTG +5.2%) outperforms after acquiring 4 fresh sets of patent portfolios (I, II, III,...\" data-tweet=\"$ACTG $ACTG $VMW - Acacia (ACTG +5.2%) outperforms after acquiring 4 fresh sets of patent portfolios (I, II, III, IV), and announcing licensing deals (I, II, III) with VMware (NYSE:VMW) and 2 other companies. The patent purchases are related to consumer... https://seekingalpha.com/news/1115602?source=tweet\" data-url=\"https://seekingalpha.com/news/1115602\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115572\" data-ts=\"1372703750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GD\" target=\"_blank\">GD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115572\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Dynamics (GD +1.1%) Electric Boat division lands a $208.6M contract modification to buy...</a></h4><p>General Dynamics (<a href=\"https://seekingalpha.com/symbol/GD\" title=\"General Dynamics Corporation\">GD</a> <font color=\"green\">+1.1%</font>) Electric Boat division lands a $208.6M contract modification to buy long lead-time material for three Virginia-class submarines. <a href=\"https://seekingalpha.com/symbol/GD\" title=\"General Dynamics Corporation\">GD</a> will start construction of two submarines per year beginning in 2011, and covers the Virginia-class submarine, SSN-793, and two FY 15 submarines, SSN-794 and SSN-795.</p><div class=\"tiny-share-widget\" data-id=\"1115572\" data-linked=\"General Dynamics (GD +1.1%) Electric Boat division lands a $208.6M contract modification to buy...\" data-tweet=\"$GD - General Dynamics (GD +1.1%) Electric Boat division lands a $208.6M contract modification to buy long lead-time material for three Virginia-class submarines. GD will start construction of two submarines per year beginning in 2011, and covers the Vi... https://seekingalpha.com/news/1115572?source=tweet\" data-url=\"https://seekingalpha.com/news/1115572\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115552\" data-ts=\"1372703113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLUU\" target=\"_blank\">GLUU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115552\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">For whatever reason, Glu Mobile (GLUU +6.3%) has rallying in sympathy with Zynga following an...</a></h4>For whatever reason, Glu Mobile (<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a> <font color='green'>+6.3%</font>) has rallying in sympathy with Zynga following an <a href=\"https://seekingalpha.com/currents/post/1115342\" target=\"_blank\">AllThingsD report</a> stating Microsoft Xbox division Don Mattrick could soon be named Zynga's CEO. 25.1% of Glu's float was shorted as of June 14, and shares closed on Friday not too far from their 52-week low of $1.99.<div class=\"tiny-share-widget\" data-id=\"1115552\" data-linked=\"For whatever reason, Glu Mobile (GLUU +6.3%) has rallying in sympathy with Zynga following an...\" data-tweet=\"$GLUU - For whatever reason, Glu Mobile (GLUU +6.3%) has rallying in sympathy with Zynga following an AllThingsD report stating Microsoft Xbox division Don Mattrick could soon be named Zynga&#39;s CEO. 25.1% of Glu&#39;s float was shorted as of June 14, and sha... https://seekingalpha.com/news/1115552?source=tweet\" data-url=\"https://seekingalpha.com/news/1115552\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115512\" data-ts=\"1372702312\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QIHU\" target=\"_blank\">QIHU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115512\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qihoo (QIHU +1.9%) is beta-testing a mobile search engine to go with Wi-Fi routers and...</a></h4><p>Qihoo (<a href=\"https://seekingalpha.com/symbol/QIHU\" title=\"QIHOO 360 Technology Co. Ltd.\">QIHU</a> <font color=\"green\">+1.9%</font>) is beta-testing a mobile search engine to go with Wi-Fi routers and English-language versions of its 360 PC/mobile security apps, <a href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/07/01/qihoo-gains-as-stifel-expects-mobile-revenue-boost/\" target=\"_blank\">says Stifel</a>, which calls the company \"in the midst of an innovation wave\" and is raising its PT to $55. The launch of a mobile search engine would amount to additional competition for Baidu (<a href=\"https://seekingalpha.com/symbol/BIDU\" title=\"Baidu, Inc.\">BIDU</a> <font color=\"red\">-1.9%</font>), which now has <a href=\"https://seekingalpha.com/currents/post/971781\" target=\"_blank\">100M+ mobile search daily users</a> (monetization is still a work-in-progress). An English version of Qihoo's 360 Mobile Safe app would likely compete with NQ Mobile's (NQ <font color=\"green\">+4.6%</font>) apps. (<a href=\"https://seekingalpha.com/currents/post/1099782\" target=\"_blank\">Baidu PC security app</a>)</p><div class=\"tiny-share-widget\" data-id=\"1115512\" data-linked=\"Qihoo (QIHU +1.9%) is beta-testing a mobile search engine to go with Wi-Fi routers and...\" data-tweet=\"$QIHU $QIHU $BIDU - Qihoo (QIHU +1.9%) is beta-testing a mobile search engine to go with Wi-Fi routers and English-language versions of its 360 PC/mobile security apps, says Stifel, which calls the company &quot;in the midst of an innovation wave&quot; and is rai... https://seekingalpha.com/news/1115512?source=tweet\" data-url=\"https://seekingalpha.com/news/1115512\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115502\" data-ts=\"1372702278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115502\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Pharmaceuticals (INO +15.8%) pop on a new report from the Center for Infectious Disease...</a></h4><p>Inovio Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/INO\" title=\"Inovio Pharmaceuticals, Inc.\">INO</a> <font color=\"green\">+15.8%</font>) pop on a <a href=\"http://www.cidrap.umn.edu/news-perspective/2013/06/poultry-contact-chronic-illness-cited-h7n9-risk-factors\" target=\"_blank\">new report</a> from the Center for Infectious Disease Research and Policy at the University of Minnesota, centering around H7N9 influenza in China and risks to infection. The three main drivers of the report were direct contact with poultry or birds, environmental exposure, and chronic conditions except for hypertension. <a href=\"https://seekingalpha.com/symbol/INO\" title=\"Inovio Pharmaceuticals, Inc.\">INO</a> <a href=\"https://seekingalpha.com/market_currents/post/1084522\" target=\"_blank\">recently announced</a> that a preclinical study of its influenza DNA vaccine against H7N9 achieved immune response levels exceeding those considered to be protective levels in other common influenza subtypes.</p><div class=\"tiny-share-widget\" data-id=\"1115502\" data-linked=\"Inovio Pharmaceuticals (INO +15.8%) pop on a new report from the Center for Infectious Disease...\" data-tweet=\"$INO - Inovio Pharmaceuticals (INO +15.8%) pop on a new report from the Center for Infectious Disease Research and Policy at the University of Minnesota, centering around H7N9 influenza in China and risks to infection. The three main drivers of the repo... https://seekingalpha.com/news/1115502?source=tweet\" data-url=\"https://seekingalpha.com/news/1115502\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115472\" data-ts=\"1372701773\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RTN\" target=\"_blank\">RTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115472\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raytheon (RTN +0.7%) has been awarded a contract with the U.S. Naval Air Systems Command to...</a></h4><p>Raytheon (<a href=\"https://seekingalpha.com/symbol/RTN\" title=\"Raytheon Company\">RTN</a> <font color=\"green\">+0.7%</font>) has been awarded a contract with the U.S. Naval Air Systems Command to build an integrated multi-INT system to safeguard forward deployed forces. The cross-domain surveillance system is a software package small enough to mount onboard an aircraft, and transfers sensor data, high-definition surveillance video, and traditional and non-traditional ISR imagery, as well as situational awareness data, to give warfighters an advantage by providing a complete picture of impending threats.</p><div class=\"tiny-share-widget\" data-id=\"1115472\" data-linked=\"Raytheon (RTN +0.7%) has been awarded a contract with the U.S. Naval Air Systems Command to...\" data-tweet=\"$RTN - Raytheon (RTN +0.7%) has been awarded a contract with the U.S. Naval Air Systems Command to build an integrated multi-INT system to safeguard forward deployed forces. The cross-domain surveillance system is a software package small enough to moun... https://seekingalpha.com/news/1115472?source=tweet\" data-url=\"https://seekingalpha.com/news/1115472\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115442\" data-ts=\"1372701519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOLNQ\" target=\"_blank\">DOLNQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115442\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of The Dolan Company (DM +13.5%) soar after SA Pro contributor Colin King&#39;s positive...</a></h4><p>Shares of The Dolan Company (<a href=\"https://seekingalpha.com/symbol/DM\" title=\"Dominion Midstream Partners LP\">DM</a> <font color=\"green\">+13.5%</font>) soar after SA Pro contributor Colin King's <a href=\"https://seekingalpha.com/article/1526102-dolan-out-the-cash\" target=\"_blank\">positive writeup</a> comes out of embargo over the weekend. Although \"patience is a must with this name,\" King says a \"growing backlog in mortgage defaults\" bodes well for the company as does Nantahala Capital's recent move to increase its stake to 11%.</p><div class=\"tiny-share-widget\" data-id=\"1115442\" data-linked=\"Shares of The Dolan Company (DM +13.5%) soar after SA Pro contributor Colin King&#39;s positive...\" data-tweet=\"$DOLNQ - Shares of The Dolan Company (DM +13.5%) soar after SA Pro contributor Colin King&#39;s positive writeup comes out of embargo over the weekend. Although &quot;patience is a must with this name,&quot; King says a &quot;growing backlog in mortgage defaults&quot; bodes we... https://seekingalpha.com/news/1115442?source=tweet\" data-url=\"https://seekingalpha.com/news/1115442\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115382\" data-ts=\"1372699619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115382\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ligand Pharmaceuticals (LGND +7.8%) posts solid gains as its Captisol licensee Onyx is the...</a></h4><p>Ligand Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/LGND\" title=\"Ligand Pharmaceuticals Incorporated\">LGND</a> <font color=\"green\">+7.8%</font>) posts solid gains as its Captisol licensee Onyx is the subject of <a href=\"https://seekingalpha.com/currents/post/1115042\" target=\"_blank\">takeout talk</a>. Cantor's Irina Rivkind <a href=\"http://www.streetinsider.com/Analyst+Comments/Ligand+Pharma+%28LGND%29+Swings+Higher%2C+but+Upside+Could+Be+Limited/8464302.html\" target=\"_blank\">isn't getting too excited</a> though, as a \"Promacta generic filer [or] any potential near-term weakness in Kyprolis or Promacta performance relative to consensus,\" could send the shares lower.</p><div class=\"tiny-share-widget\" data-id=\"1115382\" data-linked=\"Ligand Pharmaceuticals (LGND +7.8%) posts solid gains as its Captisol licensee Onyx is the...\" data-tweet=\"$LGND - Ligand Pharmaceuticals (LGND +7.8%) posts solid gains as its Captisol licensee Onyx is the subject of takeout talk. Cantor&#39;s Irina Rivkind isn&#39;t getting too excited though, as a &quot;Promacta generic filer [or] any potential near-term weakness in Ky... https://seekingalpha.com/news/1115382?source=tweet\" data-url=\"https://seekingalpha.com/news/1115382\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115372\" data-ts=\"1372699453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKR\" target=\"_blank\">BKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115372\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Baker Corporation (BKR +0.8%) says its Michael Baker Jr. unit has been awarded a...</a></h4><p>Michael Baker Corporation (<a href=\"https://seekingalpha.com/symbol/BKR\" title=\"Michael Baker Corporation\">BKR</a> <font color=\"green\">+0.8%</font>) says its Michael Baker Jr. unit has been awarded a four-year, $2.12M construction, engineering and inspection contract by the Tennessee Department of Transportation. The contract is for the replacement of a bridge over the French Broad River in Jefferson and Cocke counties in eastern Tennessee.</p><div class=\"tiny-share-widget\" data-id=\"1115372\" data-linked=\"Michael Baker Corporation (BKR +0.8%) says its Michael Baker Jr. unit has been awarded a...\" data-tweet=\"$BKR $BKR-OLD - Michael Baker Corporation (BKR +0.8%) says its Michael Baker Jr. unit has been awarded a four-year, $2.12M construction, engineering and inspection contract by the Tennessee Department of Transportation. The contract is for the replaceme... https://seekingalpha.com/news/1115372?source=tweet\" data-url=\"https://seekingalpha.com/news/1115372\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115342\" data-ts=\"1372698483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115342\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynga (ZNGA +11%) soars as Kara Swisher reports Microsoft (MSFT -0.2%) Interactive Entertainment...</a></h4><p>Zynga (<a href=\"https://seekingalpha.com/symbol/ZNGA\" title=\"Zynga\">ZNGA</a> <font color=\"green\">+11%</font>) soars as <a target=\"_blank\" href=\"http://allthingsd.com/20130701/exclusive-microsofts-entertainment-head-don-mattrick-leaving-to-take-top-role-possibly-ceo-at-zynga/?mod=atdtweet\">Kara Swisher</a> reports Microsoft (<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a> <font color=\"red\">-0.2%</font>) Interactive Entertainment (Xbox division) chief Don Mattrick is leaving, and is set to take a \"top job\" at Zynga, quite possibly that of CEO. Sources claim an announcement could arrive today. Zynga chairman/CEO Mark Pincus has taken plenty of heat from both investors and <a target=\"_blank\" href=\"http://venturebeat.com/2011/11/28/zynga-employees-give-mark-pincus-a-46-percent-approval-rating/\">employees</a> for his performance; his <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/583961\">giant share</a> of Zynga's voting rights should guarantee he'll maintain control of the company whether or not a new CEO is named.</p><div class=\"tiny-share-widget\" data-id=\"1115342\" data-linked=\"Zynga (ZNGA +11%) soars as Kara Swisher reports Microsoft (MSFT -0.2%) Interactive Entertainment...\" data-tweet=\"$ZNGA $ZNGA $MSFT - Zynga (ZNGA +11%) soars as Kara Swisher reports Microsoft (MSFT -0.2%) Interactive Entertainment (Xbox division) chief Don Mattrick is leaving, and is set to take a &quot;top job&quot; at Zynga, quite possibly that of CEO. Sources claim an ann... https://seekingalpha.com/news/1115342?source=tweet\" data-url=\"https://seekingalpha.com/news/1115342\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115332\" data-ts=\"1372698424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSM\" target=\"_blank\">INSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115332\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lazard says Arikace is &quot;still viable,&quot; which will hopefully be some consolation for Insmed (INSM...</a></h4><p>Lazard says Arikace is \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3721304/lazard-calls-insmeds-arikace-still-viable-following-comp\" target=\"_blank\">still viable</a>,\" which will hopefully be some consolation for Insmed (<a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a> <font color=\"red\">-15.4%</font>) shareholders who are taking a rather nasty hit right now courtesy of Phase 3 trial results (<a href=\"https://seekingalpha.com/currents/post/1113982\" target=\"_blank\">previous</a>) which suggested CF patients treated with Novartis' (<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a> <font color=\"green\">+0.4%</font>) Tobi performed better on lung function tests \u2014 the results were close enough however, to allow INSM to claim statistical non-inferiority. Lazard's Joshua Schimmer reiterates a Buy rating and a $24 price target. Investors are also reminded that UBS believes the drug's <a href=\"https://seekingalpha.com/currents/post/1091092\" target=\"_blank\">real potential</a> might lie in non-tuberculous mycobacteria rather than CF.</p><div class=\"tiny-share-widget\" data-id=\"1115332\" data-linked=\"Lazard says Arikace is &quot;still viable,&quot; which will hopefully be some consolation for Insmed (INSM...\" data-tweet=\"$INSM $INSM $NVS - Lazard says Arikace is &quot;still viable,&quot; which will hopefully be some consolation for Insmed (INSM -15.4%) shareholders who are taking a rather nasty hit right now courtesy of Phase 3 trial results (previous) which suggested CF patients... https://seekingalpha.com/news/1115332?source=tweet\" data-url=\"https://seekingalpha.com/news/1115332\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115292\" data-ts=\"1372697807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LAKE\" target=\"_blank\">LAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115292\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lakeland Industries (LAKE +4.9%) refinances a TD bank loan (which had technically been in...</a></h4><p>Lakeland Industries (<a href=\"https://seekingalpha.com/symbol/LAKE\" title=\"Lakeland Industries, Inc.\">LAKE</a> <font color=\"green\">+4.9%</font>) refinances a TD bank loan (which had technically been in default) with a new $15M senior credit facility, a $3.5M subordinated term loan, and the issuance of warrants. The refinancing crosses from the list one of SA Pro's Whopper Investments' worries when writing <a href=\"https://seekingalpha.com/article/1471151-it-s-time-for-a-dip-in-lakeland\" target=\"_blank\">a bullish essay</a> one month ago. Of course there's the dilution factor from the warrants, but management calls it \"very manageable\" and says it's the best of a number of offers made over the last year. The stock's up 42% since the initial article.</p><div class=\"tiny-share-widget\" data-id=\"1115292\" data-linked=\"Lakeland Industries (LAKE +4.9%) refinances a TD bank loan (which had technically been in...\" data-tweet=\"$LAKE - Lakeland Industries (LAKE +4.9%) refinances a TD bank loan (which had technically been in default) with a new $15M senior credit facility, a $3.5M subordinated term loan, and the issuance of warrants. The refinancing crosses from the list one of... https://seekingalpha.com/news/1115292?source=tweet\" data-url=\"https://seekingalpha.com/news/1115292\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115252\" data-ts=\"1372697137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115252\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: ONXX +51%. SPEX +24%. OTC:ACUR +19%. LVB +15%. DM +15%. ARIA +14%. HNR...</a></h4><b>Midday top 10 gainers:</b> <a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a> <font color=\"green\">+51%</font>. <a href=\"https://seekingalpha.com/symbol/SPEX\" title=\"Spherix Incorporated\">SPEX</a> <font color=\"green\">+24%</font>. <a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/LVB\" title=\"Steinway Musical Instruments, Inc.\">LVB</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/DM\" title=\"Dominion Midstream Partners LP\">DM</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/HNR\" title=\"Harvest Natural Resources, Inc.\">HNR</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/AXU\" title=\"Alexco Resource Corporation\">AXU</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/TRT\" title=\"Trio-Tech International\">TRT</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/ATAI\" title=\"ATA Inc.\">ATAI</a> <font color=\"green\">+11%</font>. <br><b>Midday top 10 Losers:</b> <a href=\"https://seekingalpha.com/symbol/NWSA\" title=\"News Corporation\">NWSA</a> <font color=\"red\">-54%</font>. <a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/DSS\" title=\"Document Security Systems, Inc\">DSS</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/IDCC\" title=\"InterDigital, Inc.\">IDCC</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/TXMD\" title=\"TherapeuticsMD\">TXMD</a> <font color=\"red\">-12%</font>. <a href=\"https://seekingalpha.com/symbol/HDY\" title=\"Hyperdynamics Corporation\">HDY</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/NTS\" title=\"NTS Inc\">NTS</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/PME\" title=\"Pingtan Marine Enterprise Ltd.\">PME</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/ALVR\" title=\"Alvarion Ltd.\">ALVR</a> <font color=\"red\">-9%</font>. COV <font color=\"red\">-8%</font>.<div class=\"tiny-share-widget\" data-id=\"1115252\" data-linked=\"Midday top 10 gainers: ONXX +51%. SPEX +24%. OTC:ACUR +19%. LVB +15%. DM +15%. ARIA +14%. HNR...\" data-tweet=\"$ONXX $ONXX $SPEX - Midday top 10 gainers: ONXX +51%. SPEX +24%. OTC:ACUR +19%. LVB +15%. DM +15%. ARIA +14%. HNR +13%. AXU +13%. TRT +11%. ATAI +11%. Midday top 10 Losers: NWSA -54%. INSM -15%. DSS -15%. IDCC -14%. TXMD -12%. HDY -13%. NTS -11%. PME -1... https://seekingalpha.com/news/1115252?source=tweet\" data-url=\"https://seekingalpha.com/news/1115252\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115222\" data-ts=\"1372696033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115222\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy (CHK +1.8%) completes the previously announced sale of a 50% stake in 850K...</a></h4><p>Chesapeake Energy (<a href=\"https://seekingalpha.com/symbol/CHK\" title=\"Chesapeake Energy Corporation\">CHK</a> <font color=\"green\">+1.8%</font>) completes the <a href=\"https://seekingalpha.com/currents/post/848061\" target=\"_blank\">previously announced sale</a> of a 50% stake in 850K acres  in Oklahoma for $1B to China\u2019s Sinopec (NYSE:<a href=\"https://seekingalpha.com/symbol/SNP\" title=\"China Petroleum &amp; Chemical Corporation\">SNP</a>), and the companies have created a joint venture to operate in the area, sharing exploration and development costs. The area associated with the JV produced 9,600 barrels of liquids and 54M cubic feet of natural gas per day in Q1.</p><div class=\"tiny-share-widget\" data-id=\"1115222\" data-linked=\"Chesapeake Energy (CHK +1.8%) completes the previously announced sale of a 50% stake in 850K...\" data-tweet=\"$CHK $CHK $SNP - Chesapeake Energy (CHK +1.8%) completes the previously announced sale of a 50% stake in 850K acres in Oklahoma for $1B to China\u2019s Sinopec (NYSE:SNP), and the companies have created a joint venture to operate in the area, sharing explora... https://seekingalpha.com/news/1115222?source=tweet\" data-url=\"https://seekingalpha.com/news/1115222\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115192\" data-ts=\"1372695106\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDE\" target=\"_blank\">CDE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115192\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coeur d&#39;Alene Mines (CDE -4.7%) is downgraded to Underperform with a $10 price target (from...</a></h4><p>Coeur d'Alene Mines (<a href=\"https://seekingalpha.com/symbol/CDE\" title=\"Coeur Mining, Inc.\">CDE</a> <font color=\"red\">-4.7%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3721008/update-bmo-capital-downgrades-coeur-dalene-mines-to-unde\" target=\"_blank\">downgraded</a> to Underperform with a $10 price target (from $16.50) at BMO Capital, which cites relatively high costs at its key La Preciosa project and the expected continuation of the downward trend in silver and gold prices in conjunction with CDE's high all-in-costs.</p><div class=\"tiny-share-widget\" data-id=\"1115192\" data-linked=\"Coeur d&#39;Alene Mines (CDE -4.7%) is downgraded to Underperform with a $10 price target (from...\" data-tweet=\"$CDE - Coeur d&#39;Alene Mines (CDE -4.7%) is downgraded to Underperform with a $10 price target (from $16.50) at BMO Capital, which cites relatively high costs at its key La Preciosa project and the expected continuation of the downward trend in silver and... https://seekingalpha.com/news/1115192?source=tweet\" data-url=\"https://seekingalpha.com/news/1115192\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115172\" data-ts=\"1372694629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115172\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gol Linhas (GOL -2.7%) shrugs off an upbeat initiation at Imperial Capital today to trade lower....</a></h4><p>Gol Linhas (<a href=\"https://seekingalpha.com/symbol/GOL\" title=\"GOL Linhas Aéreas Inteligentes S.A.\">GOL</a> <font color=\"red\">-2.7%</font>) shrugs off an <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3720778/update-imperial-capital-initiates-gol-linhas-with-outper\" target=\"_blank\">upbeat initiation</a> at Imperial Capital today to trade lower. The firm starts coverage with an Outperform rating and a $6 price target, saying the company is executing its turnaround plan and delivering strong results that aren't factored into the share price, largely due to investor concerns over Brazilian public protests and the weaker Real. Capacity reductions at the airline are moving average fares higher, taking the onus off relying on fare cutting as a traffic generating tool.</p><div class=\"tiny-share-widget\" data-id=\"1115172\" data-linked=\"Gol Linhas (GOL -2.7%) shrugs off an upbeat initiation at Imperial Capital today to trade lower....\" data-tweet=\"$GOL - Gol Linhas (GOL -2.7%) shrugs off an upbeat initiation at Imperial Capital today to trade lower. The firm starts coverage with an Outperform rating and a $6 price target, saying the company is executing its turnaround plan and delivering strong r... https://seekingalpha.com/news/1115172?source=tweet\" data-url=\"https://seekingalpha.com/news/1115172\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115062\" data-ts=\"1372693316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPEX\" target=\"_blank\">SPEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115062\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spherix (SPEX +38.4%) soars after saying it sold $500K worth of Series E convertible preferred...</a></h4><p>Spherix (<a href=\"https://seekingalpha.com/symbol/SPEX\" title=\"Spherix Incorporated\">SPEX</a> <font color=\"green\">+38.4%</font>) soars after saying it sold $500K worth of Series E convertible preferred to \"an investor.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1115062\" data-linked=\"Spherix (SPEX +38.4%) soars after saying it sold $500K worth of Series E convertible preferred...\" data-tweet=\"$SPEX - Spherix (SPEX +38.4%) soars after saying it sold $500K worth of Series E convertible preferred to &quot;an investor.&quot; (PR) https://seekingalpha.com/news/1115062?source=tweet\" data-url=\"https://seekingalpha.com/news/1115062\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115052\" data-ts=\"1372693233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMSC\" target=\"_blank\">AMSC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Superconductor (AMSC +4.7%) adds to its Friday gains after former customer Sinovel says...</a></h4>American Superconductor (<a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a> <font color='green'>+4.7%</font>) adds to its Friday gains after former customer Sinovel <a href=\"http://www.bloomberg.com/news/2013-07-01/china-s-sinovel-to-divest-overseas-units-after-u-s-indictment.html\" target=\"_blank\">says it will divest</a> its U.S., Belgian, Italian, and Canadian units in response to <a href=\"https://seekingalpha.com/currents/post/1112682\" target=\"_blank\">the DOJ's decision</a> to charge the company and two of its employees with stealing wind turbine controller software code from AMSC. AMSC has alleged the stolen code has been used in Sinovel wind turbines deployed in both China and international markets.<div class=\"tiny-share-widget\" data-id=\"1115052\" data-linked=\"American Superconductor (AMSC +4.7%) adds to its Friday gains after former customer Sinovel says...\" data-tweet=\"$AMSC - American Superconductor (AMSC +4.7%) adds to its Friday gains after former customer Sinovel says it will divest its U.S., Belgian, Italian, and Canadian units in response to the DOJ&#39;s decision to charge the company and two of its employees with ... https://seekingalpha.com/news/1115052?source=tweet\" data-url=\"https://seekingalpha.com/news/1115052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115042\" data-ts=\"1372693104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115042\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mid-sized cancer drug companies are enjoying a boost from Onyx&#39;s (ONXX +51%) big run today after...</a></h4><p>Mid-sized cancer drug companies are enjoying a boost from Onyx's (<a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a> <font color=\"green\">+51%</font>) big run today after the company <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1114162\">rebuffed a low-ball offer</a> from Amgen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a>). Ariad Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a> <font color=\"green\">+13%</font>), like <a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a>, has a recently approved blood-cancer drug, while  Pharmacyclics (<a href=\"https://seekingalpha.com/symbol/PCYC\" title=\"Pharmacyclics, Inc.\">PCYC</a> <font color=\"green\">+8%</font>) is considered a leader in developing a treatment for chronic lymphocytic leukemia. With <a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a> now on the block, M&amp;A fever is beginning to spread to other firms with takeover potential.</p><div class=\"tiny-share-widget\" data-id=\"1115042\" data-linked=\"Mid-sized cancer drug companies are enjoying a boost from Onyx&#39;s (ONXX +51%) big run today after...\" data-tweet=\"$ONXX $ONXX $AMGN - Mid-sized cancer drug companies are enjoying a boost from Onyx&#39;s (ONXX +51%) big run today after the company rebuffed a low-ball offer from Amgen (NASDAQ:AMGN). Ariad Pharmaceutical (ARIA +13%), like ONXX, has a recently approved blo... https://seekingalpha.com/news/1115042?source=tweet\" data-url=\"https://seekingalpha.com/news/1115042\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1115002\" data-ts=\"1372692290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AU\" target=\"_blank\">AU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1115002\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer technical analyst Carter Worth thinks the charts for gold and gold miners are so bad...</a></h4><p>Oppenheimer technical analyst Carter Worth thinks the charts for gold and gold miners are <a href=\"http://www.streetinsider.com/Analyst+Comments/Oppenheimers+Carter+Worth+Reverses+on+Gold%2C+Sees+Upside+%28AU%29+%28ABX%29+%28NEM%29+%28SLW%29/8464145.html\" target=\"_blank\">so bad they're good</a>, predicting bullion to rally 12.5% to $1,395/oz. and the miners ETF (<a href=\"https://seekingalpha.com/symbol/GDX\" title=\"VanEck Vectors Gold Miners ETF\">GDX</a> <font color=\"green\">+1.2%</font>) to climb 10%. AngloGold (<a href=\"https://seekingalpha.com/symbol/AU\" title=\"AngloGold Ashanti Limited\">AU</a> <font color=\"green\">+2.6%</font>), Goldcorp (<a href=\"https://seekingalpha.com/symbol/GG\" title=\"Goldcorp Inc.\">GG</a> <font color=\"green\">+1%</font>), Barrick (ABX <font color=\"red\">-3.2%</font>), Newmont (<a href=\"https://seekingalpha.com/symbol/NEM\" title=\"Newmont Mining Corporation (Holding Company)\">NEM</a> <font color=\"red\">-1.2%</font>) and Silver Wheaton (SLW <font color=\"green\">+3.2%</font>) are among several gold stocks Worth thinks are buys.</p><div class=\"tiny-share-widget\" data-id=\"1115002\" data-linked=\"Oppenheimer technical analyst Carter Worth thinks the charts for gold and gold miners are so bad...\" data-tweet=\"$AU $GDX $AU - Oppenheimer technical analyst Carter Worth thinks the charts for gold and gold miners are so bad they&#39;re good, predicting bullion to rally 12.5% to $1,395/oz. and the miners ETF (GDX +1.2%) to climb 10%. AngloGold (AU +2.6%), Goldcorp (GG... https://seekingalpha.com/news/1115002?source=tweet\" data-url=\"https://seekingalpha.com/news/1115002\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114992\" data-ts=\"1372692276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HXM\" target=\"_blank\">HXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114992\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexican real estate developer Homex Development (HXM +4.3%) gets a boost from a Goldman Sachs...</a></h4><p>Mexican real estate developer Homex Development (<a href=\"https://seekingalpha.com/symbol/HXM\" title=\"Desarrolladora Homex, S.A.B. de C.V. (Homex)\">HXM</a> <font color=\"green\">+4.3%</font>) gets a boost from a Goldman Sachs <a href=\"www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Homex+Development+%28HXM%29+to+Neutral/8464028.html\" target=\"_blank\">upgrade to Neutral</a> on valuation. The firm says that the the stock trades at a 22% discount on a price/book basis, instead of a premium like its peers. The reason is due to visibility and liquidity issues the company is facing, but Goldman feels these concerns have already been price into the stock.</p><div class=\"tiny-share-widget\" data-id=\"1114992\" data-linked=\"Mexican real estate developer Homex Development (HXM +4.3%) gets a boost from a Goldman Sachs...\" data-tweet=\"$HXM - Mexican real estate developer Homex Development (HXM +4.3%) gets a boost from a Goldman Sachs upgrade to Neutral on valuation. The firm says that the the stock trades at a 22% discount on a price/book basis, instead of a premium like its peers. T... https://seekingalpha.com/news/1114992?source=tweet\" data-url=\"https://seekingalpha.com/news/1114992\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114972\" data-ts=\"1372691895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLTX\" target=\"_blank\">FLTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114972\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fleetmatics (FLTX -3.6%) drops after filling a registration statement for an 8M share follow-on...</a></h4><p>Fleetmatics (<a href=\"https://seekingalpha.com/symbol/FLTX\" title=\"Fleetmatics Group PLC\">FLTX</a> <font color=\"red\">-3.6%</font>) drops after filling a registration statement for an 8M share follow-on offering. Sellers will include company officers including the CEO. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114972\" data-linked=\"Fleetmatics (FLTX -3.6%) drops after filling a registration statement for an 8M share follow-on...\" data-tweet=\"$FLTX - Fleetmatics (FLTX -3.6%) drops after filling a registration statement for an 8M share follow-on offering. Sellers will include company officers including the CEO. (PR) https://seekingalpha.com/news/1114972?source=tweet\" data-url=\"https://seekingalpha.com/news/1114972\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114962\" data-ts=\"1372691504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBIO\" target=\"_blank\">FBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114962\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coronado Biosciences (CNDO -1.9%) slips this morning, despite announcing earlier that it&#39;s...</a></h4><p>Coronado Biosciences (CNDO <font color=\"red\">-1.9%</font>) slips this morning, despite announcing earlier that it's completed the enrollment of 250 patients for its Phase 2 clinical trial of TSO, a natural immunomodulator that regulates T-Cells and pro-inflammatory cytokines to treat Crohn's disease. The trial is a U.S. multicenter study designed to evaluate the safety and efficacy of the treatment, with results from a second interim analysis expected in H213.</p><div class=\"tiny-share-widget\" data-id=\"1114962\" data-linked=\"Coronado Biosciences (CNDO -1.9%) slips this morning, despite announcing earlier that it&#39;s...\" data-tweet=\"$FBIO - Coronado Biosciences (CNDO -1.9%) slips this morning, despite announcing earlier that it&#39;s completed the enrollment of 250 patients for its Phase 2 clinical trial of TSO, a natural immunomodulator that regulates T-Cells and pro-inflammatory cyto... https://seekingalpha.com/news/1114962?source=tweet\" data-url=\"https://seekingalpha.com/news/1114962\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114942\" data-ts=\"1372691276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114942\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Piper&#39;s Regeneron (REGN +4.3%) upgrade: A 20% pull back since mid-May offers an...</a></h4><p>More on Piper's Regeneron (<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a> <font color=\"green\">+4.3%</font>) <a href=\"https://seekingalpha.com/currents/post/1114042\" target=\"_blank\">upgrade</a>: A 20% pull back since mid-May offers an \"<a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/07/3720612/update-piper-jaffray-upgrades-regeneron-pharmaceuticals-\" target=\"_blank\">attractive entry point</a> [to] one of the premier biotherapeutic plays in biotech,\" analyst Edward Tenthoff says, adding that U.S. Eylea sales should come in at $324M for Q2 and $1.368B for the year. Tenthoff also highlights the company's \"rich antibody pipeline partnered with Sanofi\" as a long-term driver of value. (Previously: Goldman says study <a href=\"https://seekingalpha.com/currents/post/1110132\" target=\"_blank\">supports Eylea</a> over off-label alternatives)</p><div class=\"tiny-share-widget\" data-id=\"1114942\" data-linked=\"More on Piper&#39;s Regeneron (REGN +4.3%) upgrade: A 20% pull back since mid-May offers an...\" data-tweet=\"$REGN - More on Piper&#39;s Regeneron (REGN +4.3%) upgrade: A 20% pull back since mid-May offers an &quot;attractive entry point [to] one of the premier biotherapeutic plays in biotech,&quot; analyst Edward Tenthoff says, adding that U.S. Eylea sales should come in a... https://seekingalpha.com/news/1114942?source=tweet\" data-url=\"https://seekingalpha.com/news/1114942\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114932\" data-ts=\"1372691267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114932\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Volatile solar stocks rally (TAN +2.7%) on what&#39;s proving a good day for risk assets, as...</a></h4><p>Volatile solar stocks rally (<a href=\"https://seekingalpha.com/symbol/TAN\" title=\"Invesco Solar Portfolio ETF\">TAN</a> <font color=\"green\">+2.7%</font>) on what's proving a good day for risk assets, as investors decide a weak Chinese manufacturing <a href=\"https://seekingalpha.com/currents/post/1113652\" target=\"_blank\">PMI print</a> was already priced in. <a href=\"https://seekingalpha.com/symbol/JKS\" title=\"JinkoSolar Holding Co., Ltd.\">JKS</a> <font color=\"green\">+7.5%</font>. SCTY <font color=\"green\">+7.1%</font>. SUNE <font color=\"green\">+6.6%</font>. <a href=\"https://seekingalpha.com/symbol/YGE\" title=\"Yingli Green Energy Holding Company Limited\">YGE</a> <font color=\"green\">+4.6%</font>. <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> <font color=\"green\">+6.2%</font>. First Solar (<a href=\"https://seekingalpha.com/symbol/FSLR\" title=\"First Solar, Inc.\">FSLR</a> <font color=\"green\">+4.4%</font>) has announced this morning construction has begun for its 50MW Macho Springs New Mexico solar project, and ReneSola (<a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+6.1%</font>) says it has restrated production at a polysilicon plant (halted in Nov.) following upgrades. ReneSola says the plant now has an annual production capacity of 10K MT, and that it expects to produce 1.8K-2K MT in Q3.</p><div class=\"tiny-share-widget\" data-id=\"1114932\" data-linked=\"Volatile solar stocks rally (TAN +2.7%) on what&#39;s proving a good day for risk assets, as...\" data-tweet=\"$JKS $TAN $JKS - Volatile solar stocks rally (TAN +2.7%) on what&#39;s proving a good day for risk assets, as investors decide a weak Chinese manufacturing PMI print was already priced in. JKS +7.5%. SCTY +7.1%. SUNE +6.6%. YGE +4.6%. LDK +6.2%. First Solar... https://seekingalpha.com/news/1114932?source=tweet\" data-url=\"https://seekingalpha.com/news/1114932\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114892\" data-ts=\"1372690610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114892\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Lions Gate (LGF +5.2%) trade higher as the prospects for a pure-play content company...</a></h4><p>Shares of Lions Gate (LGF <font color=\"green\">+5.2%</font>) trade higher as the prospects for a pure-play content company continue to look enticing with the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1114842\">bidding war</a> for exclusive content raging on. The company also scored a summertime surprise hit with <i>Now You See Me</i> on a pace to record $150M in box office sales off of a production budget of $75M.</p><div class=\"tiny-share-widget\" data-id=\"1114892\" data-linked=\"Shares of Lions Gate (LGF +5.2%) trade higher as the prospects for a pure-play content company...\" data-tweet=\"$LGF.A - Shares of Lions Gate (LGF +5.2%) trade higher as the prospects for a pure-play content company continue to look enticing with the bidding war for exclusive content raging on. The company also scored a summertime surprise hit with Now You See Me... https://seekingalpha.com/news/1114892?source=tweet\" data-url=\"https://seekingalpha.com/news/1114892\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114812\" data-ts=\"1372689050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TVTY\" target=\"_blank\">TVTY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114812\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthways (HWAY -1%) slips this morning on the announcement that it intends to privately offer...</a></h4><p>Healthways (HWAY <font color=\"red\">-1%</font>) slips this morning on the announcement that it intends to privately offer $100M in convertible senior notes due 2018, with an option to purchase up to an additional $15M. The interest rate, conversion rate and other terms of the notes have yet to be determined.</p><div class=\"tiny-share-widget\" data-id=\"1114812\" data-linked=\"Healthways (HWAY -1%) slips this morning on the announcement that it intends to privately offer...\" data-tweet=\"$TVTY - Healthways (HWAY -1%) slips this morning on the announcement that it intends to privately offer $100M in convertible senior notes due 2018, with an option to purchase up to an additional $15M. The interest rate, conversion rate and other terms o... https://seekingalpha.com/news/1114812?source=tweet\" data-url=\"https://seekingalpha.com/news/1114812\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114782\" data-ts=\"1372688637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRC\" target=\"_blank\">DRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114782\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dresser-Rand (DRC +4.3%) receives a project award from Apex Compressed Air Energy Storage for...</a></h4><p>Dresser-Rand (<a href=\"https://seekingalpha.com/symbol/DRC\" title=\"Dresser-Rand Group Inc.\">DRC</a> <font color=\"green\">+4.3%</font>) receives a project award from Apex Compressed Air Energy Storage for the supply of equipment to be used in a new 317 MW compressed air energy storage facility to be constructed in Texas, in a contract valued at ~$200M. DRC says it would be the first CAES facility to be built in the U.S. since 1991.</p><div class=\"tiny-share-widget\" data-id=\"1114782\" data-linked=\"Dresser-Rand (DRC +4.3%) receives a project award from Apex Compressed Air Energy Storage for...\" data-tweet=\"$DRC - Dresser-Rand (DRC +4.3%) receives a project award from Apex Compressed Air Energy Storage for the supply of equipment to be used in a new 317 MW compressed air energy storage facility to be constructed in Texas, in a contract valued at ~$200M. DR... https://seekingalpha.com/news/1114782?source=tweet\" data-url=\"https://seekingalpha.com/news/1114782\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114772\" data-ts=\"1372688463\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTU\" target=\"_blank\">INTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114772\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Following a halt, Intuit (INTU +4.3%) rallies in response to news it&#39;s selling its financial...</a></h4><p>Following a halt, Intuit (<a href=\"https://seekingalpha.com/symbol/INTU\" title=\"Intuit Inc.\">INTU</a> <font color=\"green\">+4.3%</font>) rallies in response to news it's <a href=\"https://seekingalpha.com/currents/post/1114262\" target=\"_blank\">selling</a> its financial services unit (exc. its <a href=\"https://www.mint.com/\" target=\"_blank\">Mint.com</a> and <a href=\"https://fi.intuit.com/\" target=\"_blank\">OFX Connectivity</a> ops) to Thoma Bravo for $1.025B. Intuit also plans to sell its <a href=\"http://healthcare.intuit.com/portal/#\" target=\"_blank\">Health Patient Portal</a> business and restructure its accounting professionals unit, and will focus on consumer tax and small business products going forward. The businesses due to be sold are expected to yield FY13 (ends in July) sales of $340M, or less than 8% of estimated revenue. Intuit will use the proceeds of the financial services sale to ramp buyback activity. Raymond James upgraded shares to Strong Buy before news of the deal broke. (<a href=\"https://seekingalpha.com/currents/post/1036441\" target=\"_blank\">May restructuring</a>)</p><div class=\"tiny-share-widget\" data-id=\"1114772\" data-linked=\"Following a halt, Intuit (INTU +4.3%) rallies in response to news it&#39;s selling its financial...\" data-tweet=\"$INTU - Following a halt, Intuit (INTU +4.3%) rallies in response to news it&#39;s selling its financial services unit (exc. its Mint.com and OFX Connectivity ops) to Thoma Bravo for $1.025B. Intuit also plans to sell its Health Patient Portal business and ... https://seekingalpha.com/news/1114772?source=tweet\" data-url=\"https://seekingalpha.com/news/1114772\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114762\" data-ts=\"1372688400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRCW\" target=\"_blank\">YRCW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114762\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of YRC Worldwide (YRCW +5.9%) shoot up after BB&amp;amp;T Capital Markers upgrades the...</a></h4>Shares of YRC Worldwide (<a href='https://seekingalpha.com/symbol/YRCW' title='YRC Worldwide, Inc.'>YRCW</a> <font color=\"green\">+5.9%</font>) shoot up after BB&amp;T Capital Markers <a target=\"_blank\" href=\"https://twitter.com/Briefingcom/status/351695053388910592\">upgrades</a> the freight company to a Buy rating. The firm created a buzz recently with its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/999731\">Q1 report</a> by recording its first positive operating income in more than a decade.<div class=\"tiny-share-widget\" data-id=\"1114762\" data-linked=\"Shares of YRC Worldwide (YRCW +5.9%) shoot up after BB&amp;amp;T Capital Markers upgrades the...\" data-tweet=\"$YRCW - Shares of YRC Worldwide (YRCW +5.9%) shoot up after BB&amp;T Capital Markers upgrades the freight company to a Buy rating. The firm created a buzz recently with its Q1 report by recording its first positive operating income in more than a decade. https://seekingalpha.com/news/1114762?source=tweet\" data-url=\"https://seekingalpha.com/news/1114762\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114662\" data-ts=\"1372687148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114662\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup&#39;s Brian Yu cuts his earnings estimates for Barrick Gold (ABX -1.8%) after the miner...</a></h4><p>Citigroup's Brian Yu <a target=\"_blank\" href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/07/01/barrick-gold-the-hits-keep-coming-but-the-stock-is-rising\">cuts his earnings estimates</a> for Barrick Gold (ABX <font color=\"red\">-1.8%</font>) after the miner says it <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1113352\">will take a $4.5B-$5.5B impairment charge</a> for the Pascua-Lama mine in Q2; he now expects ABX to earn $0.62/share in Q2 from $0.68, $3.04 in 2013 from $3.12, and $2.60 in 2014 from $2.70. Despite numerous setbacks, ABX is the low cost senior gold producer; the firm maintains its Buy rating on the stock.</p><div class=\"tiny-share-widget\" data-id=\"1114662\" data-linked=\"Citigroup&#39;s Brian Yu cuts his earnings estimates for Barrick Gold (ABX -1.8%) after the miner...\" data-tweet=\"$GOLD - Citigroup&#39;s Brian Yu cuts his earnings estimates for Barrick Gold (ABX -1.8%) after the miner says it will take a $4.5B-$5.5B impairment charge for the Pascua-Lama mine in Q2; he now expects ABX to earn $0.62/share in Q2 from $0.68, $3.04 in 201... https://seekingalpha.com/news/1114662?source=tweet\" data-url=\"https://seekingalpha.com/news/1114662\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114652\" data-ts=\"1372687102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMRN\" target=\"_blank\">BMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114652\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioMarin (BMRN +7.2%) submits a marketing application for Vimizim to Brazilian regulators from...</a></h4><p>BioMarin (<a href=\"https://seekingalpha.com/symbol/BMRN\" title=\"BioMarin Pharmaceutical Inc.\">BMRN</a> <font color=\"green\">+7.2%</font>) submits a marketing application for Vimizim to Brazilian regulators from whom the company expects a decision by H2 2014. CEO Jean-Jacques Bienaimé calls the submission \"an important milestone [given] that Brazil [is] expected to be [one of] the largest market opportunities for Vimizim.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114652\" data-linked=\"BioMarin (BMRN +7.2%) submits a marketing application for Vimizim to Brazilian regulators from...\" data-tweet=\"$BMRN - BioMarin (BMRN +7.2%) submits a marketing application for Vimizim to Brazilian regulators from whom the company expects a decision by H2 2014. CEO Jean-Jacques Bienaimé calls the submission &quot;an important milestone [given] that Brazil [is] expect... https://seekingalpha.com/news/1114652?source=tweet\" data-url=\"https://seekingalpha.com/news/1114652\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114612\" data-ts=\"1372686699\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXR\" target=\"_blank\">AXR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114612\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMREP (AXR +6.3%) gets an opening pop after reporting its rights offering - allowing existing...</a></h4><p>AMREP (<a href=\"https://seekingalpha.com/symbol/AXR\" title=\"AMREP Corporation\">AXR</a> <font color=\"green\">+6.3%</font>) gets an opening pop after reporting its rights offering - allowing existing shareholders buy about 1.2M shares at $6.25 each - was oversubscribed by roughly 1M shares. The company raised $7.5M and will have nearly 7.2M shares outstanding after the issuance. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114612\" data-linked=\"AMREP (AXR +6.3%) gets an opening pop after reporting its rights offering - allowing existing...\" data-tweet=\"$AXR - AMREP (AXR +6.3%) gets an opening pop after reporting its rights offering - allowing existing shareholders buy about 1.2M shares at $6.25 each - was oversubscribed by roughly 1M shares. The company raised $7.5M and will have nearly 7.2M shares ou... https://seekingalpha.com/news/1114612?source=tweet\" data-url=\"https://seekingalpha.com/news/1114612\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114622\" data-ts=\"1372686677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114622\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Tesla Motors (TSLA +5.5%) are driving hard again after Jefferies ups its profit...</a></h4><p>Shares of Tesla Motors (<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"green\">+5.5%</font>) are driving hard again after Jefferies <a href=\"https://twitter.com/Lebeaucarnews/status/351663570183921664\" target=\"_blank\">ups</a> its profit estimates for the company and takes it price target up to $130. The investment firm thinks the EV seller will beat 2013 productions targets.</p><div class=\"tiny-share-widget\" data-id=\"1114622\" data-linked=\"Shares of Tesla Motors (TSLA +5.5%) are driving hard again after Jefferies ups its profit...\" data-tweet=\"$TSLA - Shares of Tesla Motors (TSLA +5.5%) are driving hard again after Jefferies ups its profit estimates for the company and takes it price target up to $130. The investment firm thinks the EV seller will beat 2013 productions targets. https://seekingalpha.com/news/1114622?source=tweet\" data-url=\"https://seekingalpha.com/news/1114622\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114592\" data-ts=\"1372686483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114592\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Noodles (NDLS +7.6%) clear $40 as one of the year&#39;s most successful IPOs shows little...</a></h4>Shares of Noodles (<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+7.6%</font>) clear $40 as one of the year's most successful IPOs shows little signs of slowing down. Though the restaurant chain is being lined up by some as an early-stages Chipotle, the comparison is slightly ironic with Chipotle's (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+0.1%</font>)&nbsp; new ShopHouse concept aiming for the same part of the fast-casual market.<div class=\"tiny-share-widget\" data-id=\"1114592\" data-linked=\"Shares of Noodles (NDLS +7.6%) clear $40 as one of the year&#39;s most successful IPOs shows little...\" data-tweet=\"$NDLS $NDLS $CMG - Shares of Noodles (NDLS +7.6%) clear $40 as one of the year&#39;s most successful IPOs shows little signs of slowing down. Though the restaurant chain is being lined up by some as an early-stages Chipotle, the comparison is slightly ironi... https://seekingalpha.com/news/1114592?source=tweet\" data-url=\"https://seekingalpha.com/news/1114592\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114492\" data-ts=\"1372684969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114492\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A roundup of tech analyst ratings changes: 1) BlackBerry (BBRY) has been downgraded to...</a></h4>A roundup of tech analyst ratings changes: 1) BlackBerry (BBRY) has been downgraded to Equalweight by Morgan Stanley. 2) Broadcom (BRCM) has been downgraded to Neutral by Lazard. 3) Marvell (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) has been upgraded to Buy by Lazard. 4) F5 (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) has been upgraded to Buy by Needham. 5) Avid (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>) has been downgraded to Neutral by JPMorgan. 6) Solera (NYSE:<a href='https://seekingalpha.com/symbol/SLH' title='Solera Holdings, Inc.'>SLH</a>) has been upgraded to Outperform by William Blair. BBRY <font color=\"red\">-4.1%</font>, adding to Friday's 27% drop. BRCM <font color=\"red\">-0.6%</font>. <a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a> <font color=\"green\">+1.4%</font>. <a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a> <font color=\"green\">+2%</font>.<div class=\"tiny-share-widget\" data-id=\"1114492\" data-linked=\"A roundup of tech analyst ratings changes: 1) BlackBerry (BBRY) has been downgraded to...\" data-tweet=\"$BB $BB $AVGO - A roundup of tech analyst ratings changes: 1) BlackBerry (BBRY) has been downgraded to Equalweight by Morgan Stanley. 2) Broadcom (BRCM) has been downgraded to Neutral by Lazard. 3) Marvell (NASDAQ:MRVL) has been upgraded to Buy by Lazar... https://seekingalpha.com/news/1114492?source=tweet\" data-url=\"https://seekingalpha.com/news/1114492\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114472\" data-ts=\"1372684545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114472\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: It&#39;s a new quarter and the mood seems to be pretty good out there as U.S. stock...</a></h4><b>Market preview:</b> It's a new quarter and the mood seems to be <a target=\"_blank\" href=\"http://www.reuters.com/article/2013/07/01/us-markets-stocks-idUSBRE9600FT20130701\">pretty good</a> out there as U.S. stock futures follow many European and Asian bourses higher after a fairly torrid Q2, with the S&amp;P Mini <font color=\"green\">+0.45%</font>. The rise in the U.S. comes despite <a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=pmi\">lower-than-expected PMI</a> data in the country, although the readings in Europe were mostly decent. Onyx Pharmaceuticals <font color=\"green\">soars 54%</font> following news it's <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1113662\">very much</a> in play. <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1113522\">Later</a>: ISM Manufacturing Index, Construction Spending<div class=\"tiny-share-widget\" data-id=\"1114472\" data-linked=\"Market preview: It&#39;s a new quarter and the mood seems to be pretty good out there as U.S. stock...\" data-tweet=\"Market preview: It&#39;s a new quarter and the mood seems to be pretty good out there as U.S. stock futures follow many European and Asian bourses higher after a fairly torrid Q2, with the S&amp;P Mini +0.45%. The rise in the U.S. comes despite lower-than-expec... https://seekingalpha.com/news/1114472?source=tweet\" data-url=\"https://seekingalpha.com/news/1114472\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114462\" data-ts=\"1372684512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114462\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alnylam Pharmaceuticals (NASDAQ:ALNY) says treatment with its RNAi therapeutic ALN-TTR02 &quot;led to...</a></h4><p>Alnylam Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALNY\" title=\"Alnylam Pharmaceuticals, Inc.\">ALNY</a>) says treatment with its RNAi therapeutic ALN-TTR02 \"led to robust and statistically significant knockdown of serum TTR protein levels of up to 93%\" in a Phase 2 trial of patients with TTR-mediated amyloidosis. SA contributor Cory Renauer is <a href=\"https://seekingalpha.com/article/1526152-alnylam-s-5x15-progress-report\" target=\"_blank\">cautiously optimistic</a> on ALN-TTR02 and on ALNY in general, but notes investors may want to await a more attractive entry point. Shares <font color=\"green\">+3.55%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1114462\" data-linked=\"Alnylam Pharmaceuticals (NASDAQ:ALNY) says treatment with its RNAi therapeutic ALN-TTR02 &quot;led to...\" data-tweet=\"$ALNY - Alnylam Pharmaceuticals (NASDAQ:ALNY) says treatment with its RNAi therapeutic ALN-TTR02 &quot;led to robust and statistically significant knockdown of serum TTR protein levels of up to 93%&quot; in a Phase 2 trial of patients with TTR-mediated amyloidosi... https://seekingalpha.com/news/1114462?source=tweet\" data-url=\"https://seekingalpha.com/news/1114462\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114452\" data-ts=\"1372684446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114452\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: ONXX +54%. OTC:ACUR +26%. LVB +15%. YRCW +8%. CSIQ +7%. P +6%. NOK...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a> <font color=\"green\">+54%</font>. <a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/LVB\" title=\"Steinway Musical Instruments, Inc.\">LVB</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/YRCW\" title=\"YRC Worldwide, Inc.\">YRCW</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a> <font color=\"green\">+6%</font>.<br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a> <font color=\"red\">-27%</font>. <a href=\"https://seekingalpha.com/symbol/IDCC\" title=\"InterDigital, Inc.\">IDCC</a> <font color=\"red\">-20%</font>.<div class=\"tiny-share-widget\" data-id=\"1114452\" data-linked=\"Premarket gainers: ONXX +54%. OTC:ACUR +26%. LVB +15%. YRCW +8%. CSIQ +7%. P +6%. NOK...\" data-tweet=\"$ONXX $ONXX $ACUR - Premarket gainers: ONXX +54%. OTC:ACUR +26%. LVB +15%. YRCW +8%. CSIQ +7%. P +6%. NOK +6%.Losers: INSM -27%. IDCC -20%. https://seekingalpha.com/news/1114452?source=tweet\" data-url=\"https://seekingalpha.com/news/1114452\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114442\" data-ts=\"1372684427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSIQ\" target=\"_blank\">CSIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114442\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian Solar (NASDAQ:CSIQ) +6.7% to a new 52-week high after announcing a deal to supply 91MW...</a></h4><p>Canadian Solar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CSIQ\" title=\"Canadian Solar Inc.\">CSIQ</a>) <font color=\"green\">+6.7%</font> to a new 52-week high after announcing a deal to supply 91MW of solar modules for Thai power plant projects to Asian solar power provider Soleq Solar. Deliveries have commenced, and are expected to be finished by Q4. Shares took off last week following <a href=\"https://seekingalpha.com/currents/post/1107472\" target=\"_blank\">a Canadian deal</a> with Samsung Renewable Energy. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114442\" data-linked=\"Canadian Solar (NASDAQ:CSIQ) +6.7% to a new 52-week high after announcing a deal to supply 91MW...\" data-tweet=\"$CSIQ - Canadian Solar (NASDAQ:CSIQ) +6.7% to a new 52-week high after announcing a deal to supply 91MW of solar modules for Thai power plant projects to Asian solar power provider Soleq Solar. Deliveries have commenced, and are expected to be finished ... https://seekingalpha.com/news/1114442?source=tweet\" data-url=\"https://seekingalpha.com/news/1114442\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114432\" data-ts=\"1372684215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVB\" target=\"_blank\">LVB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114432\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Steinway Musical Instruments (NYSE:LVB) announces it will be acquired by Kohlberg &amp;amp; Company...</a></h4><p>Steinway Musical Instruments (NYSE:<a href=\"https://seekingalpha.com/symbol/LVB\" title=\"Steinway Musical Instruments, Inc.\">LVB</a>) announces it will be acquired by Kohlberg &amp; Company for $35 per share in a deal valued at $438M. The agreement will allow 45 days for Steinway to consider better offers. LVB <font color=\"green\">+15.4%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1114432\" data-linked=\"Steinway Musical Instruments (NYSE:LVB) announces it will be acquired by Kohlberg &amp;amp; Company...\" data-tweet=\"$LVB - Steinway Musical Instruments (NYSE:LVB) announces it will be acquired by Kohlberg &amp; Company for $35 per share in a deal valued at $438M. The agreement will allow 45 days for Steinway to consider better offers. LVB +15.4% premarket. https://seekingalpha.com/news/1114432?source=tweet\" data-url=\"https://seekingalpha.com/news/1114432\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114382\" data-ts=\"1372683714\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114382\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">A big surge in manufacturing in Mexico sets up well for Kansas City Southern (NYSE:KSU),...</a></h4><p>A big surge in manufacturing in Mexico <a href=\"http://online.barrons.com/article/SB50001424052748704382404578565481704373550.html#articleTabs_article%3D1\" target=\"_blank\">sets up well</a> for Kansas City Southern (NYSE:<a href=\"https://seekingalpha.com/symbol/KSU\" title=\"Kansas City Southern\">KSU</a>), according to <i>Barron's</i>. Though the company's valuation stands above peers, the growth potential tied to the railroad operator's Mexico connection and an undercurrent of speculation it could be bought out might justify a premium. KSU <font color=\"green\">+1.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1114382\" data-linked=\"A big surge in manufacturing in Mexico sets up well for Kansas City Southern (NYSE:KSU),...\" data-tweet=\"$KSU - A big surge in manufacturing in Mexico sets up well for Kansas City Southern (NYSE:KSU), according to Barron&#39;s. Though the company&#39;s valuation stands above peers, the growth potential tied to the railroad operator&#39;s Mexico connection and an under... https://seekingalpha.com/news/1114382?source=tweet\" data-url=\"https://seekingalpha.com/news/1114382\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114332\" data-ts=\"1372683207\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBY\" target=\"_blank\">BBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114332\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse takes coverage back up on Best Buy (NYSE:BBY), slotting the retailer at an...</a></h4><p>Credit Suisse takes coverage <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Credit+Suisse+Resumes+Best+Buy+%28BBY%29+at+Outperform/8463320.html\" target=\"_blank\">back up</a> on Best Buy (NYSE:<a href=\"https://seekingalpha.com/symbol/BBY\" title=\"Best Buy Co.\">BBY</a>), slotting the retailer at an Outperform rating and assigning it a very bullish price target of $40. The investment firm <a href=\"https://twitter.com/carlquintanilla/status/351678360067379201\" target=\"_blank\">cites</a> other textbook retail turnaround stories as it backs management at Best Buy to see similar success. BBY <font color=\"green\">+2.6%</font> premarket to $28.03.</p><div class=\"tiny-share-widget\" data-id=\"1114332\" data-linked=\"Credit Suisse takes coverage back up on Best Buy (NYSE:BBY), slotting the retailer at an...\" data-tweet=\"$BBY - Credit Suisse takes coverage back up on Best Buy (NYSE:BBY), slotting the retailer at an Outperform rating and assigning it a very bullish price target of $40. The investment firm cites other textbook retail turnaround stories as it backs managem... https://seekingalpha.com/news/1114332?source=tweet\" data-url=\"https://seekingalpha.com/news/1114332\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114282\" data-ts=\"1372682498\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACUR\" target=\"_blank\">ACUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114282\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acura Pharmaceuticals (OTC:ACUR) rises 22% premarket after saying Pfizer will expand the...</a></h4><p>Acura Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a>) rises <font color=\"green\">22%</font> premarket after saying Pfizer will expand the commercialization of Oxecta on which ACUR receives tiered royalties. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114282\" data-linked=\"Acura Pharmaceuticals (OTC:ACUR) rises 22% premarket after saying Pfizer will expand the...\" data-tweet=\"$ACUR - Acura Pharmaceuticals (OTC:ACUR) rises 22% premarket after saying Pfizer will expand the commercialization of Oxecta on which ACUR receives tiered royalties. (PR) https://seekingalpha.com/news/1114282?source=tweet\" data-url=\"https://seekingalpha.com/news/1114282\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114272\" data-ts=\"1372682206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EZPW\" target=\"_blank\">EZPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114272\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EZCORP (NASDAQ:EZPW) is reopened for trade, off 9.3% following a big cut in guidance and...</a></h4>EZCORP (NASDAQ:<a href='https://seekingalpha.com/symbol/EZPW' title='EZCORP, Inc.'>EZPW</a>) is reopened for trade, <font color=\"red\">off 9.3%</font> following <a href=\"https://seekingalpha.com/currents/post/1114152\" target=\"_blank\">a big cut </a>in guidance and acceleration of its plan to close smaller stores.<div class=\"tiny-share-widget\" data-id=\"1114272\" data-linked=\"EZCORP (NASDAQ:EZPW) is reopened for trade, off 9.3% following a big cut in guidance and...\" data-tweet=\"$EZPW - EZCORP (NASDAQ:EZPW) is reopened for trade, off 9.3% following a big cut in guidance and acceleration of its plan to close smaller stores. https://seekingalpha.com/news/1114272?source=tweet\" data-url=\"https://seekingalpha.com/news/1114272\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114192\" data-ts=\"1372681317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114192\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora (NYSE:P) is upped to Buy with $24 price target at Morgan Stanley, the team calling the...</a></h4><p>Pandora (NYSE:<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a>) is <a href=\"http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Pandora+%28P%29+to+Overweight/8462726.html\" target=\"_blank\">upped to Buy</a> with $24 price target at Morgan Stanley, the team calling <a href=\"https://twitter.com/carlquintanilla/status/351672322068971521\" target=\"_blank\">the company</a> \"The Netflix of Radio,\" and \"the best pureplay exposure to the secular shift of radio dollars to online channels.\" Pandora trails only Facebook and Google in monthly consumer usage, notes Morgan. Shares <font color=\"green\">+4.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1114192\" data-linked=\"Pandora (NYSE:P) is upped to Buy with $24 price target at Morgan Stanley, the team calling the...\" data-tweet=\"$P - Pandora (NYSE:P) is upped to Buy with $24 price target at Morgan Stanley, the team calling the company &quot;The Netflix of Radio,&quot; and &quot;the best pureplay exposure to the secular shift of radio dollars to online channels.&quot; Pandora trails only Facebook a... https://seekingalpha.com/news/1114192?source=tweet\" data-url=\"https://seekingalpha.com/news/1114192\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114162\" data-ts=\"1372680991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONXX\" target=\"_blank\">ONXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114162\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onyx (NASDAQ:ONXX) shares rocket 51% to $130.98 after the company says that it&#39;s rejected a...</a></h4><p>Onyx (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ONXX\" title=\"ONYX Pharmaceuticals, Inc.\">ONXX</a>) shares <font color=\"green\">rocket 51%</font> to $130.98 after the company says that it's <a href=\"https://seekingalpha.com/currents/search?query=Onyx%20Amgen\" target=\"_blank\">rejected a $120/share offer</a> from Amgen (<a href=\"https://seekingalpha.com/symbol/AMGN\" title=\"Amgen Inc.\">AMGN</a> <font color=\"green\">+0.6%</font>) and that it's seeking buyers after receiving inquiries. There's no shortage of <a href=\"http://www.thestreet.com/story/11966131/1/five-companies-likely-to-bid-for-onyx-pharma.html\" target=\"_blank\">speculation</a> about who could acquire Onyx, with Bayer (<a href=\"https://seekingalpha.com/symbol/BAYZF\" title=\"Bayer A.G.\">OTCPK:BAYZF</a>), Celgene (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CELG\" title=\"Celgene Corporation\">CELG</a>),  Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>), Bristol-Myers (NYSE:<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>), AstraZeneca (NYSE:<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a>), Eli Lilly (NYSE:<a href=\"https://seekingalpha.com/symbol/LLY\" title=\"Eli Lilly and Company\">LLY</a>), Gilead (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) and Pfizer (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) all mentioned. However, Forbes' Matthew Herper notes that potential blockbuster blood-cancer drug Kyprolis has <a href=\"http://www.forbes.com/sites/matthewherper/2013/07/01/heres-what-we-know-about-the-10-billion-bidding-war-brewing-for-onyx-pharmaceuticals\" target=\"_blank\">only received</a> accelerated FDA approval, which can be revoked. Big Pharma may have wanted to await further trial results later this year amid concerns about Kyprolis' safety.</p><div class=\"tiny-share-widget\" data-id=\"1114162\" data-linked=\"Onyx (NASDAQ:ONXX) shares rocket 51% to $130.98 after the company says that it&#39;s rejected a...\" data-tweet=\"$ONXX $ONXX $AMGN - Onyx (NASDAQ:ONXX) shares rocket 51% to $130.98 after the company says that it&#39;s rejected a $120/share offer from Amgen (AMGN +0.6%) and that it&#39;s seeking buyers after receiving inquiries. There&#39;s no shortage of speculation about who... https://seekingalpha.com/news/1114162?source=tweet\" data-url=\"https://seekingalpha.com/news/1114162\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114152\" data-ts=\"1372680962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EZPW\" target=\"_blank\">EZPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114152\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EZCORP (NASDAQ:EZPW) cuts guidance - expecting an EPS impact of greater than $0.35 in fiscal H2...</a></h4><p>EZCORP (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EZPW\" title=\"EZCORP, Inc.\">EZPW</a>) cuts guidance - expecting an EPS impact of greater than $0.35 in fiscal H2 (ending Sept. 30) - thanks to the sharp decline in gold prices and the resultant slip in margins for gold scrapping. The company accelerates its strategic plan, announcing the closing of more than 100 legacy stores (those too small to fit into the \"store within a store\" format), but reminding of the addition of 185 new stores. Shares remain <a href=\"https://seekingalpha.com/currents/post/1114092\" target=\"_blank\">halted</a>. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1114152\" data-linked=\"EZCORP (NASDAQ:EZPW) cuts guidance - expecting an EPS impact of greater than $0.35 in fiscal H2...\" data-tweet=\"$EZPW - EZCORP (NASDAQ:EZPW) cuts guidance - expecting an EPS impact of greater than $0.35 in fiscal H2 (ending Sept. 30) - thanks to the sharp decline in gold prices and the resultant slip in margins for gold scrapping. The company accelerates its stra... https://seekingalpha.com/news/1114152?source=tweet\" data-url=\"https://seekingalpha.com/news/1114152\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114042\" data-ts=\"1372679614\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGN\" target=\"_blank\">REGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114042\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regeneron (NASDAQ:REGN) gets a 1.5% premarket lift from an upgrade to Overweight from Neutral at...</a></h4><p>Regeneron (NASDAQ:<a href=\"https://seekingalpha.com/symbol/REGN\" title=\"Regeneron Pharmaceuticals, Inc.\">REGN</a>) gets a <font color=\"green\">1.5%</font> premarket lift from an <a href=\"http://www.benzinga.com/analyst-ratings/upgrades/13/07/3720048/benzingas-top-upgrades\" target=\"_blank\">upgrade to Overweight</a> from Neutral at Piper. Price target: $274.</p><div class=\"tiny-share-widget\" data-id=\"1114042\" data-linked=\"Regeneron (NASDAQ:REGN) gets a 1.5% premarket lift from an upgrade to Overweight from Neutral at...\" data-tweet=\"$REGN - Regeneron (NASDAQ:REGN) gets a 1.5% premarket lift from an upgrade to Overweight from Neutral at Piper. Price target: $274. https://seekingalpha.com/news/1114042?source=tweet\" data-url=\"https://seekingalpha.com/news/1114042\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1114022\" data-ts=\"1372679383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1114022\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen (NASDAQ:BIIB) moves up 2.69% premarket after getting an upgrade to Buy from Neutral at...</a></h4><p>Biogen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a>) moves up <font color=\"green\">2.69%</font> premarket after getting <a href=\"http://www.streetinsider.com/Upgrades/Citi+Upgrades+Biogen+%28BIIB%29+to+Buy/8462845.html\" target=\"_blank\">an upgrade to Buy</a> from Neutral at Citi. Price target is $236.</p><div class=\"tiny-share-widget\" data-id=\"1114022\" data-linked=\"Biogen (NASDAQ:BIIB) moves up 2.69% premarket after getting an upgrade to Buy from Neutral at...\" data-tweet=\"$BIIB - Biogen (NASDAQ:BIIB) moves up 2.69% premarket after getting an upgrade to Buy from Neutral at Citi. Price target is $236. https://seekingalpha.com/news/1114022?source=tweet\" data-url=\"https://seekingalpha.com/news/1114022\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1113982\" data-ts=\"1372678653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSM\" target=\"_blank\">INSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1113982\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insmed (NASDAQ:INSM) falls 18% premarket after reporting the results of a Phase 3 trial for...</a></h4><p>Insmed (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a>) falls <font color=\"red\">18%</font> premarket after reporting the results of a Phase 3 trial for Arikace. Although the treatment achieved the primary non-inferiority endpoint, it appears Arikace did not show as well as tobramycin inhalation solution in terms of FEV1 (see <a href=\"http://www.insmed.com/pdf/Insmed-ARIKACE-Phase-3-Data-Slides.pdf\" target=\"_blank\">presentation</a>, slide 3).</p><div class=\"tiny-share-widget\" data-id=\"1113982\" data-linked=\"Insmed (NASDAQ:INSM) falls 18% premarket after reporting the results of a Phase 3 trial for...\" data-tweet=\"$INSM - Insmed (NASDAQ:INSM) falls 18% premarket after reporting the results of a Phase 3 trial for Arikace. Although the treatment achieved the primary non-inferiority endpoint, it appears Arikace did not show as well as tobramycin inhalation solution ... https://seekingalpha.com/news/1113982?source=tweet\" data-url=\"https://seekingalpha.com/news/1113982\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1113832\" data-ts=\"1372670929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1113832\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia&#39;s (NYSE:NOK) shares are +7.45% at &amp;euro;3.06 in Helsinki and Siemens&#39; are +1.7% premarket...</a></h4><p>Nokia's (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) shares are <font color=\"green\">+7.45%</font> at \u20ac3.06 in Helsinki and Siemens' are <font color=\"green\">+1.7%</font>  premarket in the U.S. following news that Nokia is <a href=\"https://seekingalpha.com/currents/post/1113642\" target=\"_blank\">buying Siemens out of NSN.</a> \"With this transaction, Nokia <a href=\"http://www.reuters.com/article/2013/07/01/us-nokia-siemens-idUSBRE96004F20130701\" target=\"_blank\">buys itself a future</a>, whatever happens in smartphones and feature phones,\" Bernstein analyst Pierre Ferragu writes. JP Morgan upgrades Nokia to overweight from underweight and lifts its target price to \u20ac3.6 from \u20ac2. Regarding Siemens, Morgan Stanley is happy that despite the price being low, the conglomerate \"has managed to get this done.\"</p><div class=\"tiny-share-widget\" data-id=\"1113832\" data-linked=\"Nokia&#39;s (NYSE:NOK) shares are +7.45% at \u20ac3.06 in Helsinki and Siemens&#39; are +1.7% premarket in...\" data-tweet=\"$NOK - Nokia&#39;s (NYSE:NOK) shares are +7.45% at \u20ac3.06 in Helsinki and Siemens&#39; are +1.7% premarket in the U.S. following news that Nokia is buying Siemens out of NSN. &quot;With this transaction, Nokia buys itself a future, whatever happens in smartphones and... https://seekingalpha.com/news/1113832?source=tweet\" data-url=\"https://seekingalpha.com/news/1113832\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1113802\" data-ts=\"1372668983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEZ\" target=\"_blank\">FEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1113802\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European stocks (NYSEARCA:FEZ) are mixed following generally encouraging PMI data out of the...</a></h4><a href=\"http://www.marketwatch.com/story/europe-stocks-flat-hm-siemens-up-volvo-off-2013-07-01\" target=\"_blank\">European stocks</a> (NYSEARCA:<a href='https://seekingalpha.com/symbol/FEZ' title='SPDR EURO STOXX 50 ETF'>FEZ</a>) are mixed following generally <a href=\"https://seekingalpha.com/currents/search?query=pmi&amp;page=2\" target=\"_blank\">encouraging PMI</a> data out of the eurozone and U.K. EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"green\">+0.2%</font>, Paris <font color=\"red\">-0.1%</font>, Frankfurt <font color=\"red\">-0.6%</font>, Italy <font color=\"green\">+0.2%</font>, Madrid <font color=\"green\">+0.1%</font>.<div class=\"tiny-share-widget\" data-id=\"1113802\" data-linked=\"European stocks (NYSEARCA:FEZ) are mixed following generally encouraging PMI data out of the...\" data-tweet=\"$FEZ - European stocks (NYSEARCA:FEZ) are mixed following generally encouraging PMI data out of the eurozone and U.K. EU Stoxx 50 -0.1%, London +0.2%, Paris -0.1%, Frankfurt -0.6%, Italy +0.2%, Madrid +0.1%. https://seekingalpha.com/news/1113802?source=tweet\" data-url=\"https://seekingalpha.com/news/1113802\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1113772\" data-ts=\"1372667454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1113772\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The main Asian bourses begin the new quarter on a high note, with Japanese stocks (DXJ)...</a></h4>The main Asian bourses begin the new quarter on a high note, with Japanese stocks (<a href='https://seekingalpha.com/symbol/dxj' title='WisdomTree Japan Hedged Equity ETF'>DXJ</a>) strengthened by the Tankan survey of manufacturing sentiment <a href=\"https://seekingalpha.com/currents/post/1113672\" target=\"_blank\">turning positive</a> for the first time in 21 months. Chinese (<a href='https://seekingalpha.com/symbol/fxi' title='iShares China Large-Cap ETF'>FXI</a>) and Hong Kong (<a href='https://seekingalpha.com/symbol/ewh' title='iShares MSCI Hong Kong ETF'>EWH</a>) shares end up despite a drop in <a href=\"https://seekingalpha.com/currents/post/1113652\" target=\"_blank\">Chinese PMI</a>, a fall that was already flagged in the flash reading. Japan <font color=\"green\">+1.3%</font>, Hong Kong <font color=\"green\">+1.8%</font>, China <font color=\"green\">+0.8%</font>, India <font color=\"green\">+0.6%</font>.<div class=\"tiny-share-widget\" data-id=\"1113772\" data-linked=\"The main Asian bourses begin the new quarter on a high note, with Japanese stocks (DXJ)...\" data-tweet=\"$DXJ $FXI $EWH - The main Asian bourses begin the new quarter on a high note, with Japanese stocks (DXJ) strengthened by the Tankan survey of manufacturing sentiment turning positive for the first time in 21 months. Chinese (FXI) and Hong Kong (EWH) sha... https://seekingalpha.com/news/1113772?source=tweet\" data-url=\"https://seekingalpha.com/news/1113772\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}